Visual field defects

H7_VISFIELDDEF

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H53.4 Hospital discharge: ICD-9 — 3684 Cause of death: ICD-10 — H53.4 Cause of death: ICD-9 — 3684 2 out of 7 registries used, show all original rules.	3524
4. Check minimum number of events None	3524
5. Include endpoints None	3524
6. Filter based on genotype QC (FinnGen only)	3412

Control definitions (FinnGen only)

Control exclude: H7_VISUALDISTBLIND

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H53
Name in latin: Defectus campi visualis

NAME	H7_VISFIELDDEF
CONTROL_EXCLUDE	H7_VISUALDISTBLIND
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H534
HD_ICD_9	3684
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H534
COD_ICD_9	3684
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Visual field defects based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	23456	11336	11957
Only index persons	21057	10440	10617
Unadjusted period prevalence (%)
Whole population	0.33	0.32	0.33
Only index persons	0.39	0.38	0.41
Median age at first event (years)
Whole population	61.46	60.49	62.29
Only index persons	60.42	59.50	61.34

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3412	1758	1654
Unadjusted period prevalence (%)	0.69	0.62	0.76
Median age at first event (years)	61.63	58.13	65.35

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3524: Matched controls
35240

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

32.4

320.7

208

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

5.8

310.6

645

1308

Z01.0

ICD-10 Finland

Examination of eyes and vision

5.0

307.7

1280

3621

H53.1

ICD-10 Finland

Subjective visual disturbances

17.6

307.7

524

347

H53.4

ICD-10 Finland

Visual field defects

224050.5

307.7

3499

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

6.7

307.7

1066

2132

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

8.2

307.7

926

1468

XCK00

NOMESCO Finland

Perimetry

15.6

307.7

1092

985

AA1AD

NOMESCO Finland

CT of head and brain

4.2

307.7

1702

6465

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

8.1

259.5

369

503

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

7.1

256.0

413

648

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

8.0

254.2

363

497

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

55.3

225.9

128

H47.2

ICD-10 Finland

Optic atrophy

63.2

220.6

122

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

18.3

220.1

178

102

H53.2

ICD-10 Finland

Diplopia

24.0

217.1

156

CS494

NOMESCO Finland

Other visual field testing

8.7

214.7

282

348

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

5.6

201.1

417

832

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

17.1

200.0

167

102

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.9

199.2

692

2077

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

7.6

185.7

273

384

XA800

NOMESCO Finland

Neuropsychological investigation

6.3

185.5

332

575

E23.00

ICD-10 Finland

Panhypopituitarism

34.9

182.0

115

N03AX14

ATC

levetiracetam; systemic

7.7

181.0

263

365

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

13.6

180.2

171

132

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

9.4

177.7

218

246

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

3.9

177.4

610

1809

H53.9

ICD-10 Finland

Visual disturbance, unspecified

9.5

176.7

215

240

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.1

169.8

534

1484

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

8.8

165.2

213

256

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

63.7

157.5

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

8.5

152.7

203

253

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

4.3

152.2

431

1105

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

15.6

145.7

127

H02AB09

ATC

hydrocortisone; systemic

7.3

139.2

211

306

K90

ICPC

Stroke/cerebrovascular accident

5.9

136.7

256

461

H46

ICD-10 Finland

Optic neuritis

19.3

136.5

107

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

14.1

133.4

123

B01AC04

ATC

clopidogrel; oral

2.7

127.5

862

3756

101

Kela drug reimbursment

Anterior pituitary hypofunction

16.7

127.2

107

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

4.0

126.9

391

1062

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

3.4

112.6

453

1468

N03AF02

ATC

oxcarbazepine; oral

5.3

110.8

232

462

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

7.0

105.0

163

242

XCD10

NOMESCO Finland

Electrophysiological examination of eye

6.1

104.0

187

323

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

5.8

103.4

194

349

R51.80

ICD-10 Finland

Headache

2.7

102.8

669

2830

G40.9

ICD-10 Finland

Epilepsy, unspecified

5.0

102.0

229

484

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

8.2

100.4

135

170

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

4.0

99.8

307

829

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

4.6

99.3

248

572

N03AX18

ATC

lacosamide; systemic

16.8

97.9

H47.0

ICD-10 Finland

Disorders of optic nerve, not elsewhere classified

17.0

96.3

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

8.4

91.6

121

149

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.3

85.0

831

4200

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

4.4

84.3

218

516

102

Kela drug reimbursment

Diabetes insipidus

27.1

81.8

R4150

NOMESCO Finland

Neuropsychological rehabilitation

11.9

81.8

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

81.5

1801

12256

183

Kela drug reimbursment

Lamotrigin and topiramate

12.2

79.9

D44.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pituitary gland

26.6

79.8

R4120

NOMESCO Finland

Occupational therapy

3.2

76.9

333

1119

XCK10

NOMESCO Finland

Photography of fundus of eye

2.7

76.5

477

1956

B01AA03

ATC

warfarin; systemic

2.1

75.7

889

4806

N05BA09

ATC

clobazam; oral

17.7

74.9

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

8.8

73.8

108

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

6.5

73.5

122

194

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.5

72.7

261

780

N03AG01

ATC

valproic acid; systemic, rectal

3.3

72.4

293

945

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

6.4

70.7

119

192

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.2

69.1

734

3800

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

12.4

68.6

H53.0

ICD-10 Finland

Amblyopia ex anopsia

31.8

67.6

N18

ICPC

Paralysis/weakness

5.2

66.6

139

275

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

3.2

66.1

273

890

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

10.5

66.0

I63.8

ICD-10 Finland

Other cerebral infarction

7.9

64.7

115

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

10.5

64.2

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.2

63.7

680

3517

Z2445

NOMESCO Finland

Psychologist

4.0

63.4

189

497

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.7

62.6

367

1453

K91

ICPC

Cerebrovascular disease

6.2

61.6

107

178

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

10.7

61.3

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

5.4

61.3

123

235

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

8.1

61.0

103

H54.7

ICD-10 Finland

Unspecified visual loss

16.0

60.7

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

7.3

60.6

124

N03AB02

ATC

phenytoin; systemic

6.9

60.2

140

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.8

59.8

316

1184

L01AX03

ATC

temozolomide; systemic

9.7

58.4

Z3229

NOMESCO Finland

Other healthcare associate professional

2.5

57.9

385

1619

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

7.7

57.8

107

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

8.5

57.0

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

10.2

56.7

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.7

56.1

326

1282

PA7BD

NOMESCO Finland

CT angiography of neck and brain

5.6

56.1

107

195

R42

ICD-10 Finland

Dizziness and giddiness

1.9

55.6

879

5203

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

4.4

54.5

139

325

H47.1

ICD-10 Finland

Papilloedema, unspecified

10.7

54.2

PA6AD

NOMESCO Finland

CT of neck arteries

4.1

53.9

154

392

H34.2

ICD-10 Finland

Other retinal artery occlusions

10.2

53.1

G35

ICD-10 Finland

Multiple sclerosis

6.4

52.6

141

TAB00

NOMESCO Finland

Lumbar puncture

3.3

51.6

202

636

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

5.9

51.4

161

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

8.3

50.9

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

15.4

50.3

ZXA10

NOMESCO Finland

Bilateral

1.9

50.2

729

4177

ZXC95

NOMESCO Finland

Use of surgical navigator

6.2

49.0

138

C10AA05

ATC

atorvastatin; oral

1.7

47.9

1526

10988

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

4.0

47.1

136

349

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

4.7

47.0

110

240

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

4.0

45.8

131

334

B01AC07

ATC

dipyridamole; systemic

2.9

45.7

233

854

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.0

45.5

582

3182

H40.11

ICD-10 Finland

Low pressure glaucoma

4.1

45.3

127

319

AA4BG

NOMESCO Finland

MRI examination of sella turcica with high intensity magnet

18.2

44.7

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

4.6

44.4

106

235

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

9.7

43.9

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

7.9

43.8

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

6.2

43.0

122

ZXD05

NOMESCO Finland

Urgent procedure

1.7

43.0

1098

7404

N03AF01

ATC

carbamazepine; oral, rectal

2.8

42.8

230

867

AA5PD

NOMESCO Finland

CT examination of brain pefusion

6.5

42.6

110

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

5.4

42.6

158

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

4.8

42.3

204

N03AX09

ATC

lamotrigine; oral

3.1

42.2

178

586

F05

ICPC

Visual disturbance other

3.7

41.9

137

384

G45.3

ICD-10 Finland

Amaurosis fugax

4.8

41.4

204

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

5.0

40.6

180

R47.0

ICD-10 Finland

Dysphasia and aphasia

6.0

39.3

116

Z3231

NOMESCO Finland

Registered nurse

1.7

39.1

982

6559

I63

ICD-10 Finland

Cerebral infarction

6.8

39.0

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

7.1

38.6

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

5.7

38.4

129

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

7.7

36.5

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

36.4

599

3537

I60.1

ICD-10 Finland

Subarachnoid haemorrhage from middle cerebral artery

8.0

36.2

109

Kela drug reimbursment

Multiple sclerosis

6.5

36.2

XCH00

NOMESCO Finland

Eye pressure measurement

2.7

36.2

203

781

D35.30

ICD-10 Finland

Craniopharyngoma

361.0

36.0

C03CA01

ATC

furosemide; systemic

1.6

35.5

1152

8172

H47.3

ICD-10 Finland

Other disorders of optic disc

10.7

34.9

AAF00

NOMESCO Finland

Ventriculostomy

7.6

34.8

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.5

34.8

124

368

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.2

34.4

219

R53

ICD-10 Finland

Malaise and fatigue

1.7

34.3

831

5467

G40.10

ICD-10 Finland

Simple partial seizures

7.2

33.9

WX892

NOMESCO Finland

Monitored bed care

2.2

33.4

304

1456

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

33.2

288

1353

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

33.1

895

6051

G81.9

ICD-10 Finland

Hemiplegia, unspecified

5.4

32.7

123

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

3.4

32.7

120

363

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

4.0

32.6

241

N03AX11

ATC

topiramate; oral

3.8

32.6

100

268

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

32.6

1437

10879

H01AC01

ATC

somatropin; parenteral

11.9

32.5

N29

ICPC

Neurological sympt/complt other

3.9

32.3

256

C10AA01

ATC

simvastatin; oral

1.5

32.3

1512

11588

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.8

32.3

164

599

N19

ICPC

Speech disorder

4.5

32.0

180

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

11.1

32.0

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

4.3

31.9

197

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

31.8

841

5643

A28

ICPC

Limited function/disability NOS

1.7

31.8

660

4156

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

8.6

31.4

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

31.3

766

5039

Z2446

NOMESCO Finland

Social worker

2.3

31.0

246

1112

ZXC86

NOMESCO Finland

Use of endoscopic device

7.8

31.0

N06AX11

ATC

mirtazapine; oral

1.6

30.8

1115

8056

M03BX01

ATC

baclofen; systemic

3.9

30.3

236

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

30.2

817

5503

315

Kela drug reimbursment

Clopidogrel

4.9

30.2

140

C07AB07

ATC

bisoprolol; oral

1.5

30.1

1713

13610

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

6.9

30.1

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

30.1

502

2965

D32.01

ICD-10 Finland

Benign tumor of meninges on interhemispheric surface

8.1

29.9

G41.9

ICD-10 Finland

Status epilepticus, unspecified

7.1

28.0

N02BE01

ATC

paracetamol; systemic, rectal

1.7

27.6

3028

27457

H54.3

ICD-10 Finland

Mild or no visual impairment, binocular

28.7

27.6

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

27.5

664

4336

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

27.4

1133

8376

L28

ICPC

Limited function/disability (L)

1.7

27.3

642

4162

H40.0

ICD-10 Finland

Glaucoma suspect

2.0

27.1

297

1524

114

Kela drug reimbursment

Glaucoma

1.9

27.0

344

1860

R20.2

ICD-10 Finland

Paraesthesia of skin

2.2

26.4

231

1087

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

26.3

456

2718

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

9.5

26.2

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.2

26.1

223

1039

SPAT1229

SPAT

Assessment of need for aid

2.0

26.1

300

1566

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

25.8

747

5089

WX872

NOMESCO Finland

Intensive care

2.3

25.8

202

908

R50.9

ICD-10 Finland

Fever, unspecified

1.7

25.7

511

3164

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

4.9

25.5

116

A02BC02

ATC

pantoprazole; systemic

1.5

25.4

2259

19311

H02AB06

ATC

prednisolone; systemic

1.5

25.4

1580

12620

G43.9

ICD-10 Finland

Migraine, unspecified

2.4

25.4

177

756

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

25.3

537

3383

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

25.3

1197

9067

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

25.3

963

6976

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

25.2

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

8.0

25.1

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

25.1

1053

7782

G40

ICD-10 Finland

Epilepsy

5.5

25.1

T90.5

ICD-10 Finland

Sequelae of intracranial injury

4.6

24.7

127

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

24.7

2079

17544

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

5.1

24.5

101

N03AX12

ATC

[U] gabapentin; oral

1.7

24.3

543

3465

G44.2

ICD-10 Finland

Tension-type headache

1.8

24.3

421

2505

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

24.3

421

2506

G91.0

ICD-10 Finland

Communicating hydrocephalus

6.9

24.2

C07AB02

ATC

metoprolol; systemic

1.6

24.1

719

4927

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.9

24.1

311

1689

N03AG04

ATC

vigabatrin; oral

56.4

24.0

H53.8

ICD-10 Finland

Other visual disturbances

5.1

24.0

AA4CM

NOMESCO Finland

Extensive MRI examination of sella turcica with 3 Tesla magnet

37.8

23.9

C09AA05

ATC

ramipril; oral

1.5

23.9

879

6307

N06AB04

ATC

citalopram; systemic

1.6

23.9

673

4549

XF404

NOMESCO Finland

Ambulatory ECG

1.9

23.5

316

1738

N28

ICPC

Limited function/disability (N)

3.5

23.3

227

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

23.3

535

3437

H03AA01

ATC

levothyroxine sodium; systemic

1.6

23.2

741

5151

PA2AD

NOMESCO Finland

CT angiography of brain

5.4

23.1

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

9.1

23.0

3684A

ICD-9 Finland

Visual disturbances, Visual field defects[HOMONYYMIT NÄKÖKENTTÄPUUTOKSET]

+∞

22.9

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

8.6

22.8

181

Kela drug reimbursment

Retigabine and vigabatrin

84.0

22.7

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

2.7

22.6

123

466

N88

ICPC

Epilepsy

6.4

22.6

G40.89

ICD-10 Finland

Other epilepsy

7.0

22.5

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

22.4

395

2359

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

22.3

357

2073

R06.0

ICD-10 Finland

Dyspnoea

1.5

22.1

896

6542

H33.0

ICD-10 Finland

Retinal detachment with retinal break

2.7

22.1

118

443

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.5

21.8

218

S01ED51

ATC

timolol, combinations; ophthalmic

1.9

21.7

285

1554

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.5

21.7

120

H34.1

ICD-10 Finland

Central retinal artery occlusion

6.1

21.6

PA2LT

NOMESCO Finland

Endovascular closure of extensive brain aneurysm

8.8

21.5

H54.4

ICD-10 Finland

Blindness, monocular

31.3

21.5

WX882

NOMESCO Finland

High dependency care

2.8

21.4

110

405

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.8

21.4

368

2182

Z3226

NOMESCO Finland

Physiotherapist

1.6

21.3

605

4086

207

Kela drug reimbursment

Chronic arrhythmias

1.6

21.3

561

3722

ZXY02

NOMESCO Finland

Neuropsychologist

6.8

21.2

S01EE01

ATC

latanoprost; ophthalmic

2.0

21.1

241

1253

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

21.0

357

2109

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.2

21.0

179

834

N03AE01

ATC

clonazepam; systemic

2.1

20.7

193

931

C71.40

ICD-10 Finland

Malignant tumor of the occipital lobe without histology

77.3

20.7

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

20.6

522

3429

A02BC01

ATC

omeprazole; systemic

1.5

20.6

894

6604

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

6.3

20.5

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

20.4

576

3883

H26.4

ICD-10 Finland

After-cataract

1.8

20.3

350

2077

SPAT1216

SPAT

Assessment of functional ability

1.6

20.1

539

3587

I50.0

ICD-10 Finland

Congestive heart failure

1.9

20.0

285

1595

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

19.9

873

6454

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

19.9

1081

8320

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

19.8

1134

8810

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

19.8

377

2300

H52.1

ICD-10 Finland

Myopia

2.7

19.6

108

412

ZXE00

NOMESCO Finland

One hour or less

1.4

19.6

1239

9790

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.5

19.6

119

477

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

19.5

357

2153

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

4.3

19.2

115

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

3.8

19.2

159

AAB30

NOMESCO Finland

Evacuation of spontaneous intracranial haematoma

18.3

19.1

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

3.8

19.0

151

R1260

NOMESCO Finland

Evaluation of communicative skills

3.2

19.0

238

AAL10

NOMESCO Finland

Intracranial endovascular thrombolysis

5.5

18.8

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

18.8

581

3989

B01AB05

ATC

enoxaparin; parenteral

1.4

18.7

1017

7809

H54.1

ICD-10 Finland

Severe visual impairment, binocular

70.3

18.7

SPAT1260

SPAT

Consultation of another employee

1.6

18.7

560

3819

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.4

18.5

129

551

E23.2

ICD-10 Finland

Diabetes insipidus

14.2

18.5

Z02.4

ICD-10 Finland

Examination for driving licence

0.6

18.4

485

7060

R4110

NOMESCO Finland

Physiotherapy

1.4

18.4

885

6642

S06.0

ICD-10 Finland

Concussion

1.7

18.4

335

2016

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.0

18.4

285

G43.3

ICD-10 Finland

Complicated migraine

3.6

18.4

164

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.0

18.4

203

1044

G50.1

ICD-10 Finland

Atypical facial pain

3.4

18.3

198

I60.0

ICD-10 Finland

Subarachnoid haemorrhage from carotid siphon and bifurcation

6.9

18.2

N02AX02

ATC

tramadol; systemic, rectal

1.4

18.2

1380

11201

9530/0-C70.9

ICD-O-3

Meningioma, NOS, of meninges, NOS

17.6

18.2

C71.20

ICD-10 Finland

Malignant tumor in temporal lobe without histology

19.4

18.2

ZXC40

NOMESCO Finland

Use of ultrasound

5.2

18.1

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

18.1

891

6712

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

18.1

501

3355

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

18.0

939

7148

ZXA05

NOMESCO Finland

Left side

1.5

17.8

804

5957

R55

ICD-10 Finland

Syncope and collapse

1.7

17.8

370

2307

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

13.7

17.7

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

2.8

17.7

319

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

4.0

17.6

123

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

5.0

17.6

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

17.5

210

1111

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

17.5

777

5738

PA2AC

NOMESCO Finland

Cerebral angiography with X-ray

6.8

17.4

CKD40

NOMESCO Finland

Endophotocoagulation of retina

3.4

17.4

185

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

17.4

324

1963

H50.1

ICD-10 Finland

Divergent concomitant strabismus

6.0

17.3

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.7

17.1

353

2197

H35.6

ICD-10 Finland

Retinal haemorrhage

5.3

17.0

N05CF01

ATC

zopiclone; oral

1.4

16.9

1031

8049

C08CA01

ATC

amlodipine; oral

1.4

16.9

1264

10209

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

16.8

329

2019

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

5.7

16.8

SPAT1254

SPAT

Administration of medicine

1.6

16.8

486

3284

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

6.3

16.7

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.8

16.7

137

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

16.7

143

668

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.1

16.6

157

763

WX140

NOMESCO Finland

Parabulbar anesthesy

2.1

16.5

164

811

Q21.11

ICD-10 Finland

Paten or persistent foramen ovale

6.0

16.5

J01DB01

ATC

cefalexin; oral

1.4

16.5

2691

24500

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

16.5

274

1607

G91.1

ICD-10 Finland

Obstructive hydrocephalus

6.1

16.4

L04AA06

ATC

mycophenolic acid; systemic

3.1

16.4

223

H50.0

ICD-10 Finland

Convergent concomitant strabismus

6.3

16.3

280

Kela drug reimbursment

Clopidogrel

3.1

16.2

224

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

16.2

892

6835

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

16.2

526

3644

I69

ICD-10 Finland

Sequelae of cerebrovascular disease

6.8

16.1

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

15.9

529

3680

N03AX16

ATC

[U] pregabalin

1.4

15.9

713

5263

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

5.7

15.9

W19

ICD-10 Finland

Unspecified fall

1.7

15.9

311

1909

H35.5

ICD-10 Finland

Hereditary retinal dystrophy

12.3

15.8

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

15.7

839

6389

R4130

NOMESCO Finland

Speech therapy

2.5

15.7

375

R3120

NOMESCO Finland

Training in mobility skills

7.2

15.7

S01EC04

ATC

brinzolamide; ophthalmic

2.1

15.6

152

747

SPAT1297

SPAT

Other function in accordance with speech therapy nomenclature

5.6

15.5

M79.6

ICD-10 Finland

Pain in limb

1.4

15.5

1253

10208

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

15.4

228

1290

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

15.4

2193

19404

XF620

NOMESCO Finland

Examination of circulation with color method

5.8

15.4

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

15.4

305

1878

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

5.0

15.2

N86

ICPC

Multiple sclerosis

5.9

15.2

WX402

NOMESCO Finland

General anaesthesia

1.5

15.1

621

4503

SPAT1263

SPAT

Sampling

1.3

15.1

1292

10598

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

3.8

15.1

119

301

Kela drug reimbursment

Growth hormone

20.1

15.1

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

4.2

15.0

XCH05

NOMESCO Finland

Eye pressure longterm registration

3.9

14.9

111

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

14.9

1063

8479

CK2A4

NOMESCO Finland

Autofluorescence imaging of ocular fundus

6.8

14.9

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

2.6

14.8

326

L03AB07

ATC

interferon beta-1a; parenteral

5.9

14.8

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

4.0

14.8

103

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

5.5

14.8

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

14.6

221

1259

SPAT1301

SPAT

No procedures

1.4

14.6

973

7672

A46

ICD-10 Finland

Erysipelas

1.5

14.6

466

3212

R11

ICD-10 Finland

Nausea and vomiting

1.7

14.5

265

1596

AN1

Coronary angiography

1.6

14.5

378

2491

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

14.4

1212

9904

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.0

14.3

149

750

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

14.3

928

7284

WX704

NOMESCO Finland

Intubation

1.7

14.2

249

1481

S01EA05

ATC

brimonidine; ophthalmic

2.4

14.2

394

N05BA01

ATC

diazepam; systemic, rectal

1.6

14.1

397

2659

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

14.1

1190

9718

N01

ICPC

Headache

1.7

14.0

285

1766

N04BC06

ATC

cabergoline; oral

5.4

14.0

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

14.0

126

601

N06AB10

ATC

escitalopram; oral

1.5

14.0

554

3986

N02AA05

ATC

oxycodone; systemic

1.5

14.0

579

4202

S18

ICPC

Laceration/cut

1.3

13.9

1423

11939

3454A

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]

15.8

13.9

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

13.9

196

1094

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

3.7

13.9

117

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

1.9

13.7

167

888

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

13.7

1359

11346

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

13.7

446

3085

J01FF01

ATC

clindamycin; systemic

1.4

13.7

813

6284

A06AD11

ATC

lactulose; oral

1.5

13.7

486

3422

XX3DW

NOMESCO Finland

Time consuming IT work

1.6

13.5

345

2260

PAW37

NOMESCO Finland

Biopsy of temporal artery

4.5

13.5

H53

ICD-10 Finland

Visual disturbances

4.7

13.5

R02

ICPC

Shortness of breath/dyspnoea

1.5

13.5

391

2636

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

13.5

225

1321

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

13.4

548

3962

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

13.4

141

714

AAD15

NOMESCO Finland

Evacuation of traumatic intracerebral haematoma

18.3

13.4

R51

ICD-10 Finland

Headache

2.0

13.3

148

763

G93.2

ICD-10 Finland

Benign intracranial hypertension

21.2

13.3

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

13.3

424

2918

R04.0

ICD-10 Finland

Epistaxis

1.7

13.3

246

1486

H57.1

ICD-10 Finland

Ocular pain

2.2

13.2

106

483

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.0

13.2

143

731

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

13.2

598

4409

N17

ICPC

Vertigo/dizziness

1.5

13.2

373

2502

ZY010

NOMESCO Finland

Hospital outpatient

2.0

13.1

140

712

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

13.1

728

5559

B01AF02

ATC

apixaban; oral

1.5

13.1

410

2811

C71.2

ICD-10 Finland

Malignant neoplasm: Temporal lobe

15.1

13.1

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

13.0

167

904

A04

ICPC

Weakness/tiredness general

1.5

13.0

443

3092

E89.30

ICD-10 Finland

Postprocedural hypopituitarism

28.5

12.9

PA6CG

NOMESCO Finland

Extensive MRI examination of neck vasculature with high intensity magnet

9.3

12.9

Z2221

NOMESCO Finland

Medical doctor

1.4

12.9

824

6432

C03DA01

ATC

spironolactone; oral

1.5

12.9

387

2628

205

Kela drug reimbursment

Chronic hypertension

1.4

12.9

903

7152

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.7

12.9

269

1677

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.8

12.8

178

990

C09CA06

ATC

candesartan; oral

1.4

12.7

695

5288

H35.4

ICD-10 Finland

Peripheral retinal degeneration

4.2

12.7

Angiography of the heart and coronary arteries

1.7

12.6

217

1285

K89

ICPC

Transient cerebral ischaemia

3.4

12.6

130

9350/1-C75.2

ICD-O-3

Craniopharyngioma, NOS, of craniopharyngeal duct

70.1

12.6

I60.7

ICD-10 Finland

Subarachnoid haemorrhage from intracranial artery, unspecified

6.0

12.6

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

12.6

374

2536

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

12.5

802

6261

D32.04

ICD-10 Finland

Secondary or multiple benign tumor of the meninges above the exam

17.4

12.5

G81.1

ICD-10 Finland

Spastic hemiplegia

20.1

12.4

N91.1

ICD-10 Finland

Secondary amenorrhoea

3.5

12.4

117

I60.2

ICD-10 Finland

Subarachnoid haemorrhage from anterior communicating artery

4.9

12.4

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

12.3

233

1417

ZXD35

NOMESCO Finland

Usual procedure

2.2

12.3

106

498

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

12.3

411

2857

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.6

12.2

295

1906

C09CA01

ATC

losartan; oral

1.4

12.2

793

6201

WX002

NOMESCO Finland

Sedation and analgesia

1.4

12.1

596

4451

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.9

12.1

150

803

K78

ICPC

Atrial fibrillation/flutter

1.6

12.1

261

1641

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.9

12.1

152

818

A12BA01

ATC

potassium chloride; oral

1.9

12.1

154

833

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.5

12.1

119

L17

ICPC

Foot/toe symptom/complaint

1.3

12.0

846

6699

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

9.3

12.0

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

9.3

12.0

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

5.0

11.9

D33.00

ICD-10 Finland

Medial pilosytic astrocytoma of the cerebrum

13.4

11.9

S01EC01

ATC

acetazolamide; systemic

2.5

11.9

314

C01DA14

ATC

isosorbide mononitrate; oral

1.4

11.8

527

3871

A02BC05

ATC

esomeprazole; systemic

1.3

11.8

1219

10184

E22.1

ICD-10 Finland

Hyperprolactinaemia

4.3

11.7

N99

ICPC

Neurological disease other

3.1

11.7

162

R1250

NOMESCO Finland

Evaluation of functional capability

2.5

11.7

292

H50.31

ICD-10 Finland

Intermittent exotropia

4.6

11.6

C71.22

ICD-10 Finland

Malignant tumor of temporal lobe grade III glioma

30.1

11.6

N05BA04

ATC

oxazepam; oral

1.4

11.6

762

5962

C71.43

ICD-10 Finland

Malignant tumor of the occipital lobe grade IV glioma

65.2

11.6

I25.2

ICD-10 Finland

Old myocardial infarction

1.7

11.6

233

1439

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

2.4

11.5

349

XCW10

NOMESCO Finland

Assessment of vision

2.9

11.5

185

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

11.5

112

551

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

8.6

11.5

H47.4

ICD-10 Finland

Disorders of optic chiasm

+∞

11.5

H53.3

ICD-10 Finland

Other disorders of binocular vision

13.6

11.4

H02.4

ICD-10 Finland

Ptosis of eyelid

2.2

11.4

414

CKD10

NOMESCO Finland

Insufflation of vitreous cavity

2.6

11.4

254

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

11.4

243

1525

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.8

11.3

184

1072

D32.03

ICD-10 Finland

Benign meningioma in ventricles

11.8

11.3

SPAT1252

SPAT

Overall medication plan or its review

1.7

11.3

216

1318

C71.21

ICD-10 Finland

Malignant tumor of temporal lobe grade II glioma

35.1

11.3

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.7

11.2

192

1135

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

11.2

147

802

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

8.9

11.2

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

11.2

641

4905

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

3.7

11.2

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

11.2

225

1390

J01FA06

ATC

roxithromycin; oral

1.3

11.2

1198

10035

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

4.6

11.2

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

4.6

11.2

C10AX09

ATC

ezetimibe; oral

1.4

11.1

462

3345

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

11.1

1054

8687

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.7

11.0

218

1341

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

11.0

595

4510

R60.0

ICD-10 Finland

Localized oedema

1.5

10.9

368

2558

A03

ICPC

Fever

1.4

10.9

434

3119

L04AX01

ATC

azathioprine; systemic

2.0

10.8

122

634

N05CD08

ATC

midazolam; nasal, systemic

2.3

10.8

347

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

8.3

10.8

E23.05

ICD-10 Finland

Lack of TSH

8.3

10.8

PA2YT

NOMESCO Finland

Cerebral artery PTA with stent

8.8

10.7

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

8.8

10.7

S01EC54

ATC

brinzolamide, combinations; ophthalmic

2.8

10.7

187

N05AH04

ATC

quetiapine; oral

1.4

10.7

479

3516

9531/0-C70.0

ICD-O-3

Meningothelial meningioma of cerebral meninges

21.5

10.7

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

10.6

141

773

H02AB04

ATC

methylprednisolone; systemic

1.4

10.6

419

3004

H54.0

ICD-10 Finland

Blindness, binocular

60.2

10.6

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

10.6

407

2903

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

5.3

10.6

A02BA02

ATC

ranitidine; systemic

1.4

10.6

585

4450

B01AB04

ATC

dalteparin; parenteral

1.8

10.6

160

914

J01MA02

ATC

ciprofloxacin; systemic

1.3

10.6

1203

10139

P20

ICPC

Memory disturbance

1.4

10.5

441

3199

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

4.5

10.5

N06AX21

ATC

duloxetine; oral

1.5

10.5

318

2164

AA4DG

NOMESCO Finland

Very extensive MRI examination of sella turcica with high intensity magnet

14.2

10.5

N03AX23

ATC

brivaracetam; systemic

14.2

10.5

AAC40

NOMESCO Finland

Extirpation of intracranial arterio-venous malformation

110.3

10.4

L04AA01

ATC

[U] ciclosporin

3.0

10.4

152

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.4

10.4

106

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

2.0

10.4

113

580

N03AX22

ATC

perampanel; oral

16.1

10.3

S06.3

ICD-10 Finland

Focal brain injury

2.9

10.3

158

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

10.3

279

1852

A02BC03

ATC

lansoprazole; oral

1.3

10.3

871

7057

127

Kela drug reimbursment

Transplant complication

2.8

10.3

175

2273A

ICD-9 Finland

Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)

18.8

10.3

N06AA09

ATC

amitriptyline; systemic

1.5

10.2

280

1865

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

2.6

10.1

216

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

10.1

350

2446

CKC12

NOMESCO Finland

Photocoagulation of retina

1.9

10.1

120

635

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

4.2

10.1

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

10.1

1222

10364

C71.23

ICD-10 Finland

Malignant tumor of temporal lobe grade IV glioma

14.6

10.0

C71.4

ICD-10 Finland

Malignant neoplasm: Occipital lobe

40.2

10.0

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

10.0

188

1143

N02BF01

ATC

gabapentin; oral

1.6

9.9

226

1441

X58

ICD-10 Finland

Exposure to other specified factors

1.5

9.9

377

2685

G46.4*I67.9

ICD-10 Finland

Cerebellar stroke syndrome

4.2

9.9

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

9.9

1246

10612

G91.8

ICD-10 Finland

Other hydrocephalus

16.7

9.9

S01EE05

ATC

tafluprost; ophthalmic

1.9

9.9

115

605

C09AA02

ATC

enalapril; systemic

1.4

9.8

611

4729

F01.10

ICD-10 Finland

Multi-infarct dementia without additional symptoms

12.2

9.8

I50.1

ICD-10 Finland

Left ventricular failure

1.7

9.8

162

949

H50.52

ICD-10 Finland

Exophoria

3.6

9.8

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.9

9.8

152

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.2

9.8

343

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

9.8

247

1614

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

9.8

551

4201

I69.2

ICD-10 Finland

Sequelae of other nontraumatic intracranial haemorrhage

9.5

9.7

C10AA03

ATC

pravastatin; oral

1.6

9.7

226

1448

CS2P4

NOMESCO Finland

Optic nerve head imaging

3.3

9.7

111

SPAT1153

SPAT

Removal of sutures

1.3

9.7

954

7875

A29

ICPC

General symptom/complaint other

1.5

9.7

366

2603

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

13.4

9.7

UKC02

NOMESCO Finland

Cystoscopy

1.4

9.6

507

3823

H54.5

ICD-10 Finland

Severe visual impairment, monocular

7.8

9.6

H33.5

ICD-10 Finland

Other retinal detachments

3.6

9.5

AAA27

NOMESCO Finland

Insertion of intracerebral pressure monitoring device

15.1

9.5

C08CA13

ATC

lercanidipine; oral

1.4

9.5

430

3161

R13

ICD-10 Finland

Dysphagia

1.6

9.5

209

1323

D68.8

ICD-10 Finland

Other specified coagulation defects

3.2

9.5

118

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

3.2

9.4

113

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.5

9.4

255

1693

9380/3-C71.9

ICD-O-3

Glioma, malignant of brain, NOS

100.3

9.4

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

9.4

375

J01DA01

ATC

[U] cefalexin

1.2

9.4

1899

17039

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

9.4

314

2180

C72.3

ICD-10 Finland

Malignant neoplasm: Optic nerve

+∞

9.4

SAA04

NOMESCO Finland

Special examination of mouth

1.8

9.3

147

850

D35.31

ICD-10 Finland

Cyst in Rathke's pocket

21.7

9.3

2151

FHL

Resection, big brain

21.7

9.3

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

9.3

242

1591

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.2

9.3

331

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

3.4

9.3

SPAT1053

SPAT

Memory test

1.4

9.3

459

3423

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

4.7

9.3

H51.1

ICD-10 Finland

Convergence insufficiency and excess

9.5

9.3

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.2

9.2

332

RS221, ,

NOMESCO Finland

2.7

9.2

174

XA400

NOMESCO Finland

EEG

4.1

9.2

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.7

9.2

164

982

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

9.2

538

4122

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.8

9.2

129

722

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

9.1

180

1107

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

9.1

474

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

9.1

368

2649

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.6

9.1

235

1544

R06AE07

ATC

cetirizine; oral

1.3

9.1

1240

10632

H25.0

ICD-10 Finland

Senile incipient cataract

1.6

9.1

195

1226

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

9.1

220

1424

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

4.4

9.1

PA2KT

NOMESCO Finland

Endovascular closure of brain aneurysm

8.3

9.1

WF002

NOMESCO Finland

Radical radiotherapy

1.7

9.0

168

1018

R1250, ,

SPAT

2.5

9.0

211

H43.3

ICD-10 Finland

Other vitreous opacities

2.8

9.0

154

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

9.0

218

1412

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.7

9.0

173

1059

GBB00

NOMESCO Finland

Tracheostomy

2.8

8.9

149

XF402

NOMESCO Finland

ECG with work load test

1.5

8.9

309

2159

C71.30

ICD-10 Finland

Malignant tumor in parietal lobe without histology

18.6

8.9

PA2DG

NOMESCO Finland

Very extensive MRI examination of vessels in the head with high intensity magnet

18.6

8.9

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

8.9

480

3629

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

7.4

8.9

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

8.9

627

4938

D33.05

ICD-10 Finland

Other lateral benign tumor in temporal lobe

24.1

8.9

WX725

NOMESCO Finland

Noninvasive ventilation

1.7

8.9

155

923

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

8.9

371

2686

N06AX16

ATC

venlafaxine; oral

1.4

8.9

360

2593

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.6

8.9

221

1440

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.6

8.8

192

1211

G93.0

ICD-10 Finland

Cerebral cysts

4.9

8.8

A01

ICPC

Pain general/multiple sites

1.5

8.8

256

1726

SPAT1234

SPAT

Support of social functional capacity

1.7

8.8

161

972

A10AB05

ATC

insulin aspart; parenteral

1.6

8.7

224

1469

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.9

8.7

104

552

Z71.8

ICD-10 Finland

Other specified counselling

1.3

8.7

844

6937

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

8.7

130

741

R51.81

ICD-10 Finland

Facial pain NOS

2.2

8.7

302

AAK00

NOMESCO Finland

Cranioplasty

14.0

8.7

F28

ICPC

Limited function/disability (F)

3.9

8.7

PA2HT

NOMESCO Finland

Extensive embolisation of arterio-venous malformation of the brain

50.1

8.7

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.5

8.6

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.4

8.6

228

S00.0

ICD-10 Finland

Superficial injury of scalp

2.2

8.6

329

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

4.4

8.6

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

4.4

8.6

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.7

8.6

143

841

PD5AD

NOMESCO Finland

CT of aorta

2.2

8.6

323

SPAT1251

SPAT

Organisation of medication

1.9

8.6

110

598

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

8.6

285

1977

AAK80

NOMESCO Finland

Partial excision of skull cap

16.3

8.5

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

8.5

709

5711

RS222, ,

NOMESCO Finland

2.8

8.5

142

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

8.5

240

1608

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

10.0

8.5

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

3.5

8.5

N04BB01

ATC

amantadine; oral

2.6

8.5

188

C71.29

ICD-10 Finland

Malignant tumor in temporal lobe other or unspecified histology

27.6

8.5

G80.2

ICD-10 Finland

Spastic hemiplegic cerebral palsy

20.1

8.5

H26.2

ICD-10 Finland

Complicated cataract

2.7

8.4

154

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

8.4

1137

9717

S01ED01

ATC

timolol; ophthalmic

1.9

8.4

110

602

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.8

8.4

120

675

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

8.4

199

1283

L16

ICPC

Ankle symptom/complaint

1.5

8.4

309

2187

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

1.8

8.4

127

728

L03AX13

ATC

glatiramer acetate; parenteral

6.7

8.3

9400/3-C71.2

ICD-O-3

Astrocytoma, NOS, of temporal lobe

+∞

8.3

AA4AD

NOMESCO Finland

CT of sella turcica

+∞

8.3

AAK85

NOMESCO Finland

Replantation of previously excised part of skull cap

+∞

8.3

WX730

NOMESCO Finland

Conventional respirator

2.5

8.3

202

H52.2

ICD-10 Finland

Astigmatism

2.4

8.2

227

ZX050

NOMESCO Finland

Stereotactic radiotherapy

2.9

8.2

123

CHD65

NOMESCO Finland

Nonpenetrating glaucoma surgery

3.2

8.2

NC2AA

NOMESCO Finland

Forearm X-ray examination

2.6

8.2

174

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

8.2

192

1235

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

8.1

744

6064

A10AE04

ATC

insulin glargine; parenteral

1.5

8.1

279

1948

R41.3

ICD-10 Finland

Other amnesia

1.9

8.1

495

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.6

8.1

185

1183

R52.2

ICD-10 Finland

Other chronic pain

1.9

8.1

104

567

K77

ICPC

Heart failure

2.1

8.1

325

R20.1

ICD-10 Finland

Hypoaesthesia of skin

4.0

8.1

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.6

8.1

196

1271

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

6.8

8.1

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

8.0

201

1312

D33.08

ICD-10 Finland

Another benign tumor of the cerebral ventricle

22.1

8.0

Z94.0

ICD-10 Finland

Kidney transplant status

2.9

8.0

125

SPAT1293

SPAT

Other function in accordance with rehabilitation guidance nomenclature

3.6

8.0

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.5

8.0

188

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

3.5

8.0

H26.02

ICD-10 Finland

Presenil cataract

2.1

7.9

354

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

3.7

7.9

H02AB07

ATC

prednisone; oral

1.4

7.9

392

2925

I61.8

ICD-10 Finland

Other intracerebral haemorrhage

6.6

7.9

SPAT1097

SPAT

Recording of ECG

1.4

7.8

421

3180

S01EE03

ATC

bimatoprost; ophthalmic

2.1

7.8

363

H35.0

ICD-10 Finland

Background retinopathy and retinal vascular changes

3.8

7.8

H25.8

ICD-10 Finland

Other senile cataract

1.4

7.8

335

2439

C10AA07

ATC

rosuvastatin; oral

1.3

7.8

897

7518

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.0

7.7

371

I60.4

ICD-10 Finland

Subarachnoid haemorrhage from basilar artery

15.0

7.7

137

Kela drug reimbursment

Uraemia requiring dialysis

3.1

7.7

101

SPAT1262

SPAT

Handing over of treatment supplies

1.3

7.7

517

4041

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

7.6

180

1159

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.6

7.6

161

1010

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.7

7.6

143

871

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.2

7.6

274

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

7.6

296

2117

L04AA31

ATC

[U] teriflunomide

8.0

7.6

L04AX07

ATC

dimethyl fumarate; oral

8.0

7.6

A41.9

ICD-10 Finland

Sepsis, unspecified

1.8

7.6

108

608

Z50.1

ICD-10 Finland

Other physical therapy

1.6

7.6

152

941

R52.9

ICD-10 Finland

Pain, unspecified

1.5

7.5

256

1783

C08CA05

ATC

nifedipine; systemic

1.6

7.5

183

1188

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

7.5

1261

11002

H02AB02

ATC

dexamethasone; systemic

1.4

7.5

320

2327

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

7.5

169

1078

H34.8

ICD-10 Finland

Other retinal vascular occlusions

2.1

7.5

322

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

3.9

7.4

H47.7

ICD-10 Finland

Disorder of visual pathways, unspecified

80.3

7.4

C71.49

ICD-10 Finland

Malignant tumor in occipital lobe other or unspecified histology

80.3

7.4

M03BX02

ATC

tizanidine; oral

1.2

7.4

1781

16101

D21

ICPC

Swallowing problem

2.3

7.4

220

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

7.6

7.4

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

7.6

7.4

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

3.4

7.4

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

3.7

7.3

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

2.4

7.3

202

P01AB01

ATC

metronidazole; oral, rectal

1.2

7.3

1119

9660

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.6

7.3

149

926

I20.09

ICD-10 Finland

Unstable angina

1.6

7.3

173

1115

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.5

7.3

227

1553

C09AA04

ATC

perindopril; oral

1.6

7.3

146

903

N80

ICPC

Head injury other

2.2

7.3

272

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

7.3

317

2311

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

7.3

1053

9035

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

3.0

7.3

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

7.3

449

AAJ10

NOMESCO Finland

Lobectomy for epilepsy

+∞

7.3

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

4.1

7.3

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

7.3

264

1864

4340A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral thrombosis

2.7

7.2

138

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

2.2

7.2

254

D33.2

ICD-10 Finland

Benign neoplasm: Brain, unspecified

15.8

7.2

XFE00

NOMESCO Finland

Epicardial ultrasonography

2.0

7.2

347

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

7.2

193

1281

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

7.2

175

1137

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.1

7.1

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.9

7.1

446

RK320, ,

NOMESCO Finland

3.2

7.1

UDC00

NOMESCO Finland

Ear microscopy

1.5

7.1

200

1342

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

7.1

340

2522

J01CA04

ATC

amoxicillin; systemic

1.2

7.1

2530

23735

H30.9

ICD-10 Finland

Chorioretinal inflammation, unspecified

12.0

7.1

D32.07

ICD-10 Finland

Secondary or multiple benign tumor of the meninges below the exam

12.0

7.1

SPAT1240

SPAT

Therapeutic discussion

1.5

7.1

242

1689

ZXA00

NOMESCO Finland

Right side

1.3

7.1

784

6530

R90.0

ICD-10 Finland

Intracranial space-occupying lesion

8.8

7.0

C01BD01

ATC

amiodarone; systemic

1.9

7.0

448

A07AA02

ATC

nystatin; oral

1.6

7.0

164

1055

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

1.9

7.0

420

ZX120

NOMESCO Finland

Intravenous

1.4

7.0

265

1885

TFP20

NOMESCO Finland

Cardiodefibrillation

1.5

7.0

212

1444

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

7.0

2080

19146

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.7

7.0

129

783

M04AA01

ATC

allopurinol; systemic

1.3

7.0

402

3070

I67.8

ICD-10 Finland

Other specified cerebrovascular diseases

4.4

7.0

XCD20

NOMESCO Finland

Photoangiography of eye

2.2

6.9

239

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

6.9

1075

9285

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

6.9

266

1900

S22

ICPC

Nail symptom/complaint

1.6

6.9

169

1100

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.0

6.9

388

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

6.8

268

1919

M79.1

ICD-10 Finland

Myalgia

1.4

6.8

371

2807

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

6.8

103

591

AA9CW, ,

NOMESCO Finland

8.3

6.8

164

Kela drug reimbursment

Fingolimod

8.3

6.8

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.2

6.8

241

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

4.1

6.8

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

6.8

160

1031

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.6

6.8

162

1047

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.6

6.8

143

897

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

6.8

172

1127

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.8

6.8

489

N74

ICPC

Malignant neoplasm nervous system

10.9

6.8

R35

ICD-10 Finland

Polyuria

1.5

6.8

196

1322

G41.0

ICD-10 Finland

Grand mal status epilepticus

9.3

6.8

N76

ICPC

Neoplasm nervous system unspecified

9.3

6.8

SPAT1101

SPAT

Orthostatic test

1.7

6.8

130

797

H53.5

ICD-10 Finland

Colour vision deficiencies

40.1

6.8

G40.50

ICD-10 Finland

Epilepsia partialis continua [Kozhevnikof]

40.1

6.8

D35.3

ICD-10 Finland

Benign neoplasm: Craniopharyngeal duct

40.1

6.8

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

6.8

148

938

XKC03

NOMESCO Finland

Water cystometry

1.9

6.8

447

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.3

6.7

405

3111

C71.33

ICD-10 Finland

Malignant tumor of parietal lobe grade IV glioma

16.7

6.7

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

2.2

6.7

262

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

6.7

316

2336

A11

ICPC

Chest pain NOS

1.5

6.7

224

1556

CA1ME

NOMESCO Finland

Ultrasound oculometry

3.2

6.7

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

3.2

6.7

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.2

6.7

243

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.5

6.7

176

1164

2542

FHL

Transasal hypophysectomy

22.6

6.7

I61.2

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, unspecified

22.6

6.7

E23.0

ICD-10 Finland

Hypopituitarism

22.6

6.7

D32

ICD-10 Finland

Benign neoplasm of meninges

22.6

6.7

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

1.7

6.7

105

610

Z00.8

ICD-10 Finland

Other general examinations

1.5

6.7

198

1344

A02BA04

ATC

nizatidine; systemic

1.5

6.6

214

1477

I44.2

ICD-10 Finland

Atrioventricular block, complete

1.8

6.6

479

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

7.8

6.6

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

6.6

293

2145

C01AA05

ATC

digoxin; systemic

1.4

6.6

247

1755

R03AC02

ATC

salbutamol; inhalant

1.2

6.6

1591

14329

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

2.3

6.6

194

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

6.5

1295

11443

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.3

6.5

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.5

6.5

193

1308

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.0

6.5

312

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.7

6.5

107

629

G36.9

ICD-10 Finland

Acute disseminated demyelination, unspecified

10.0

6.5

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

2.8

6.5

106

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.8

6.5

467

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

3.0

6.5

J01MA12

ATC

levofloxacin; systemic

1.3

6.5

529

4240

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.6

6.5

140

885

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.1

6.5

273

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

6.4

270

1957

J01FA01

ATC

erythromycin; systemic

1.4

6.4

332

2491

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.1

6.4

260

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.0

6.4

307

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

6.4

499

3973

WF099

NOMESCO Finland

Other radiotherapy

3.1

6.4

AA1ED

NOMESCO Finland

Trauma CT of head and neck

3.5

6.4

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

6.4

247

1763

9440/3-C71.4

ICD-O-3

Glioblastoma, NOS, of occipital lobe

70.0

6.4

E22.80

ICD-10 Finland

Central precocious puberty

70.0

6.4

D33.0

ICD-10 Finland

Benign neoplasm: Brain, supratentorial

70.0

6.4

F01.9

ICD-10 Finland

Vascular dementia, unspecified

2.2

6.4

215

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

6.4

155

1006

H54.6

ICD-10 Finland

Moderate visual impairment, monocular

7.4

6.4

F05.9

ICD-10 Finland

Delirium, unspecified

2.0

6.4

329

Z00.0

ICD-10 Finland

General medical examination

1.3

6.4

529

4251

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.7

6.3

567

K92.1

ICD-10 Finland

Melaena

1.6

6.3

154

1001

D32.05

ICD-10 Finland

Cerebral meninges

8.2

6.3

AAL00

NOMESCO Finland

Endovascular occlusion of intracranial aneurysm

8.2

6.3

E23.01

ICD-10 Finland

Isolated deficiency of growth hormone

8.2

6.3

F29

ICPC

Eye symptom/complaint other

1.4

6.3

236

1676

H40.9

ICD-10 Finland

Glaucoma, unspecified

2.1

6.3

289

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

2.3

6.3

185

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.9

6.3

400

SPAT1310

SPAT

Counselling related to known health issue

1.2

6.3

889

7591

F01.1

ICD-10 Finland

Multi-infarct dementia

11.0

6.3

WZC30

NOMESCO Finland

Teaching

1.3

6.3

435

3410

SPAT1050

SPAT

Extensive neurological examination

2.0

6.3

310

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

3.3

6.3

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

6.3

515

4131

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

6.3

134

845

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

2.9

6.3

AWC00

NOMESCO Finland

Reoperation of nervous system because of deep wound infection in the nervous system

18.0

6.3

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.8

6.3

437

C71.42

ICD-10 Finland

Malignant tumor of the occipital lobe grade III glioma

+∞

6.3

9350/1-C75.1

ICD-O-3

Craniopharyngioma, NOS, of pituitary gland

+∞

6.3

I20.00

ICD-10 Finland

Unstable angina

1.8

6.2

510

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

2.7

6.2

120

C08DB01

ATC

diltiazem; oral

1.6

6.2

157

1029

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.8

6.2

474

NHQ40

NOMESCO Finland

Amputation of toe

2.2

6.2

218

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.4

6.2

307

2288

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

3.0

6.2

S50.0

ICD-10 Finland

Contusion of elbow

1.9

6.2

388

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

2.8

6.2

109

B01AE07

ATC

dabigatran etexilate; oral

1.7

6.2

115

700

B05DA

ATC

Isotonic solutions

3.1

6.2

J01FA10

ATC

azithromycin; systemic

1.2

6.2

1586

14332

C01BC04

ATC

flecainide; systemic

1.8

6.1

520

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

3.4

6.1

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.3

6.1

194

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.0

6.1

334

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.7

6.1

115

703

I49.5

ICD-10 Finland

Sick sinus syndrome

1.7

6.1

110

665

I34.1

ICD-10 Finland

Mitral (valve) prolapse

1.9

6.1

398

N30.0

ICD-10 Finland

Acute cystitis

1.3

6.1

427

3355

C71.11

ICD-10 Finland

Malignant tumor of frontal lobe grade II glioma

8.6

6.0

9440/3-C71.9

ICD-O-3

Glioblastoma, NOS, of brain, NOS

8.6

6.0

PA7CC

NOMESCO Finland

Very extensive angiography of arteries of neck and brain

8.6

6.0

M89.0

ICD-10 Finland

Algoneurodystrophy

3.1

6.0

UJF32

NOMESCO Finland

Coloscopy

1.2

6.0

748

6297

N06AA10

ATC

nortriptyline; systemic

2.1

6.0

274

2152

FHL

Extraction, big brain

6.7

6.0

AA1AM

NOMESCO Finland

Short MRI examination of brain with 3 Tesla magnet

10.0

6.0

S06.2

ICD-10 Finland

Diffuse brain injury

2.7

6.0

111

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1607

8598

2.60

162.55

2.6

2.1

165.36

236.61

u/l

2.74

1532

8040

(3018677) aPTT in Platelet poor plasma by Coagulation assay

996

4406

2.76

145.30

2.7

2.1

29.32

29.93

2.78

962

4272

(3022217) INR in Platelet poor plasma by Coagulation assay

2050

13777

2.17

106.07

21.7

16.2

1.59

1.31

inr

0.70

650

4016

(3013826) Glucose [Moles/volume] in Serum or Plasma

2340

16925

2.14

95.20

6.4

4.7

6.64

6.80

mmol/l

3.57

2243

15859

(3036481) Cortisol [Moles/volume] in Serum or Plasma

557

2528

2.43

71.87

3.4

2.1

357.33

372.70

nmol/l

0.49

512

2305

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1862

13153

1.88

71.77

7.5

6.0

1.20

1.21

mmol/l

5.12

1721

11958

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1993

14542

1.85

67.69

8.3

6.8

1.21

mmol/l

3.42

1660

12277

(3044290) Cell count panel - Cerebral spinal fluid

194

500

4.05

66.90

1.7

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

107

174

6.31

63.05

1.7

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

209

630

3.46

57.27

1.6

1.3

623.49

532.87

mg/l

0.78

200

596

(3021387) Prolactin [Units/volume] in Serum or Plasma

234

762

3.22

56.64

3.4

1.5

355.67

304.62

mu/l

0.99

221

694

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1564

11051

1.75

54.90

4.8

3.7

82.22

54.03

ng/l

0.35

1179

7840

(3003396) Base excess in Arterial blood by calculation

641

3424

2.07

54.31

7.8

7.4

0.95

1.22

mmol/l

0.96

505

2689

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

642

3435

2.06

54.13

7.8

7.4

5.03

5.10

kpa

1.10

610

3260

(3027801) Oxygen [Partial pressure] in Arterial blood

641

3434

2.06

53.84

7.8

7.4

13.57

12.12

kpa

6.84

606

3256

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

186

554

3.49

51.88

1.7

1.5

1320.26

1434.89

e6/l

0.05

160

462

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

186

554

3.49

51.88

1.7

1.4

21.25

25.80

e6/l

0.15

151

438

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

115

246

4.80

50.29

1.9

1.6

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

182

561

3.37

48.09

1.4

1.3

3.66

3.88

mmol/l

1.93

168

533

(3023368) Bacteria identified in Blood by Culture

1216

8244

1.73

47.70

4.7

4.4

—

(3016018) Differential panel - Cerebral spinal fluid

110

242

4.66

46.50

1.7

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

116

6.58

46.39

2.5

2.2

56.79

50.24

umol/l

0.73

(3036489) Thrombin time

262

1014

2.71

46.34

2.8

2.0

21.47

21.75

0.30

218

904

(3018418) pH of Serum or Plasma

1252

8645

1.70

45.37

4.5

4.0

7.40

0.28

287

1663

(3024561) Albumin [Mass/volume] in Serum or Plasma

1686

12611

1.65

44.58

5.4

4.8

35.10

35.15

g/l

0.14

1579

11724

(3033658) Prothrombin time (PT) actual/Normal

1086

7269

1.71

43.84

4.8

3.9

88.77

88.24

0.26

1059

7085

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

187

4.91

40.75

1.6

1.3

2.23

2.04

mmol/l

0.48

178

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

173

5.01

39.43

1.2

1.1

46.92

39.76

mg/l

0.58

144

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

781

4889

1.77

39.35

2.0

1.8

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

159

5.19

39.16

1.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

765

4770

1.77

39.04

3.8

3.3

0.82

mmol/l

0.38

714

4458

(3016502) Oxygen saturation in Arterial blood

541

3059

1.91

37.79

8.7

7.8

96.01

95.59

0.89

516

2937

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

170

4.91

37.24

1.1

261.63

272.65

mg/l

0.19

146

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

11.26

37.12

2.1

1.1

—

(3026008) Bacteria identified in Urine by Culture

1246

8996

1.60

35.67

3.6

3.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2284

18934

1.59

35.60

5.6

4.6

2902.83

1859.85

e6/l

0.20

291

(3002173) Hemoglobin [Mass/volume] in Arterial blood

500

2809

1.91

35.47

9.2

8.2

121.53

121.08

g/l

0.19

481

2726

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1890

15016

1.56

35.47

6.6

6.2

11.02

11.79

umol/l

2.37

1762

14263

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

133

5.35

35.10

1.8

1.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2582

22079

1.63

34.97

8.7

7.5

79.83

79.49

u/l

0.11

2423

20798

(3013115) Eosinophils [#/volume] in Blood

1846

14628

1.55

34.76

7.1

5.9

0.19

e9/l

0.72

1641

12773

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

128

5.40

34.45

1.7

—

(3001604) Monocytes [#/volume] in Blood

1791

14124

1.55

34.28

6.8

5.7

0.61

0.60

e9/l

0.39

1590

12161

(3006315) Basophils [#/volume] in Blood

1793

14155

1.54

34.06

6.8

5.7

0.04

e9/l

0.64

1590

12177

(3019198) Lymphocytes [#/volume] in Blood

1817

14500

1.52

32.04

6.9

5.8

1.80

1.91

e9/l

1.54

1634

12779

(40760892) CBC W Ordered Manual Differential panel - Blood

1690

13289

1.52

31.89

7.9

6.3

—

(3023410) Appearance of Cerebral spinal fluid

241

3.94

31.81

1.7

1.6

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

362

1897

2.01

31.28

8.5

7.0

24.72

24.57

mmol/l

0.39

342

1793

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

204

850

2.49

30.88

3.5

2.2

96.09

91.33

2.57

191

822

(3003458) Phosphate [Moles/volume] in Serum or Plasma

622

3882

1.73

30.85

6.4

5.9

1.03

1.04

mmol/l

0.31

581

3601

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1186

8716

1.54

30.18

3.4

3.0

1769.92

1622.76

ng/l

0.48

1014

7499

(3013707) Erythrocyte sedimentation rate by Westergren method

2449

20973

1.55

30.05

4.7

4.0

13.07

12.78

mm/h

0.41

2291

19346

(3037467) Urinalysis macro (dipstick) panel - Urine

2318

19691

1.52

28.85

5.4

4.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

121

401

3.09

28.37

4.0

5.1

345.01

352.34

umol/l

0.19

106

351

(3019060) Gas panel - Arterial blood

367

1999

1.93

28.26

6.5

5.0

—

(3020779) Urea [Moles/volume] in Serum or Plasma

459

2690

1.81

28.09

7.5

7.3

9.22

10.30

mmol/l

2.46

423

2558

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

548

3404

1.72

27.37

1.9

1.8

—

(3019069) Monocytes/100 leukocytes in Blood

1670

13370

1.47

27.21

7.6

6.3

8.78

8.69

0.55

1596

12496

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

546

3397

1.72

27.09

1.8

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1984

16445

1.47

26.94

9.6

8.8

4.29

4.18

e9/l

1.17

1772

14323

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

225

3.75

26.68

1.0

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

824

5708

1.58

26.66

4.6

3.8

232.17

569.61

ng/l

1.14

631

4610

(3006504) Eosinophils/100 leukocytes in Blood

1657

13295

1.46

26.41

7.3

5.9

2.77

2.83

0.47

1583

12411

(3019309) Folate [Moles/volume] in Red Blood Cells

823

5711

1.58

26.39

1.9

1.8

1167.36

1169.37

nmol/l

0.02

621

4303

(3022096) Basophils/100 leukocytes in Blood

1610

12898

1.46

25.57

7.3

6.0

0.64

0.67

0.86

1535

12012

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

179

768

2.40

25.41

3.3

2.4

183.95

193.56

0.68

171

733

(3002030) Lymphocytes/100 leukocytes in Blood

1688

13706

1.44

24.61

7.4

6.0

26.28

27.27

3.13

1614

12840

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

128

4.59

24.51

1.1

1.24

1.18

u/l

0.13

(3018010) Neutrophils/100 leukocytes in Blood

1665

13493

1.44

24.48

7.0

5.8

58.61

57.69

2.32

1591

12629

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

147

4.28

23.94

1.1

1.2

1.09

1.05

ratio

0.94

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

430

2586

1.75

23.90

2.5

2.3

5.71

6.77

ug/l

0.90

367

2256

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3076

28268

1.69

23.49

21.2

14.9

22.96

24.86

mg/l

2.74

2609

22592

(3030467) Casts [#/volume] in Urine by Automated count

1084

8147

1.48

23.41

3.9

3.2

0.43

0.47

e6/l

0.24

879

6238

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1024

7610

1.49

23.40

2.5

2.3

3.03

3.00

mg/l

0.12

871

6470

(3019550) Sodium [Moles/volume] in Serum or Plasma

3153

29182

1.76

23.33

25.3

17.3

139.48

139.63

mmol/l

2.42

3088

28426

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

854

6119

1.52

23.26

2.1

1.7

1.23

1.30

mg/l

0.23

651

4709

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

5.01

22.99

3.5

2.6

30.14

29.00

umol/l

0.25

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1649

13439

1.43

22.96

2.9

2.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

258

3.31

22.39

2.5

1.5

—

(3008295) Osmolality of Serum or Plasma

304

3.12

22.38

1.7

1.4

283.46

278.64

mosm/kgh2o

1.19

229

(3023103) Potassium [Moles/volume] in Serum or Plasma

3155

29265

1.75

22.36

25.4

17.5

3.97

3.98

mmol/l

1.29

3084

28458

(3026782) Osmolality of Urine

833

5991

1.51

22.12

3.4

2.9

522.80

545.66

mosm/kgh2o

2.26

744

5156

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2433

21347

1.45

22.04

4.7

3.9

14.87

14.83

pmol/l

0.33

2207

19347

(36304419) Bacteria [Presence] in Urine

1049

7911

1.46

21.97

3.8

3.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

286

1557

1.91

21.92

8.9

9.5

23.95

24.36

mmol/l

1.33

278

1510

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

6.93

21.63

1.3

1.2

—

(3039000) Anion gap in Blood

156

682

2.35

21.25

9.6

7.8

11.09

11.26

mmol/l

0.25

139

609

(3018572) Chloride [Moles/volume] in Blood

156

683

2.34

21.18

9.6

7.8

104.76

105.11

mmol/l

0.31

139

610

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1489

12033

1.41

21.14

2.1

2.0

95.30

94.30

pmol/l

0.33

798

6271

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

107

392

2.78

21.02

1.3

1.2

6.62

3.89

u/ml

0.77

171

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

103

370

2.84

20.99

1.1

121.62

115.66

1.13

340

(3051593) INR in Capillary blood by Coagulation assay

145

4.05

20.92

10.2

14.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1161

8997

1.43

20.78

3.0

2.5

60.96

68.51

u/l

0.33

1070

8290

(3022948) Iron [Moles/volume] in Serum or Plasma

673

4684

1.54

20.66

2.8

2.5

12.10

12.83

umol/l

1.80

610

4374

(3009214) Lutropin [Units/volume] in Serum or Plasma

147

635

2.37

20.58

1.9

1.4

9.68

9.96

u/l

0.08

111

519

(3044640) Blood type and Crossmatch panel - Blood

1179

9183

1.43

20.43

2.7

2.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

5.05

20.43

1.1

1.0

—

(3047181) Lactate [Moles/volume] in Blood

197

965

2.10

20.32

8.6

6.7

1.30

1.31

mmol/l

0.03

173

842

(3035637) Corticotropin [Mass/volume] in Plasma

319

2.93

20.01

2.0

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

288

1621

1.85

19.87

11.3

10.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

235

1244

1.95

19.55

7.7

5.6

0.90

0.89

0.18

217

1167

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

17.79

19.53

1.1

—

(3002582) Erythrocytes [#/volume] in Urine

1145

8937

1.42

19.37

4.1

3.3

63.12

82.88

e6/l

0.70

935

6907

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

145

3.91

19.28

1.1

—

(3000850) Epithelial cells [#/volume] in Urine

846

6259

1.46

19.10

3.2

2.6

5.03

5.38

e6/l

0.41

779

5637

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

104

4.47

18.91

1.0

1.1

95.49

94.04

0.12

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

315

1849

1.77

18.90

9.1

8.9

1.43

1.34

1.04

315

1837

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

208

1069

2.01

18.84

4.1

2.9

0.40

0.34

u/ml

1.40

122

615

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

313

1836

1.77

18.82

9.4

9.1

0.70

0.68

0.60

313

1821

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1429

11626

1.39

18.78

2.5

2.2

76.26

77.93

nmol/l

1.45

1297

10358

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

198

1004

2.03

18.62

2.2

2.3

342.01

545.44

ug/l

1.29

190

943

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

233

1253

1.92

18.50

7.7

5.6

1.76

1.65

0.70

214

1175

(3005719) IgG [Mass/volume] in Serum or Plasma

340

2054

1.73

18.43

3.0

2.7

10.65

10.51

g/l

0.20

305

1868

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2824

25786

1.48

18.43

5.4

4.7

1.87

2.07

mu/l

1.51

2563

23498

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

351

2141

1.71

18.37

1.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

161

760

2.17

18.28

2.0

1.6

0.23

0.24

g/l

0.42

149

717

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

104

407

2.60

18.01

1.4

1.2

6.18

2.46

u/ml

0.71

139

(3003181) Sodium [Moles/volume] in Urine

121

510

2.42

17.92

1.6

1.3

74.27

62.61

mmol/l

1.70

105

400

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

164

786

2.14

17.92

2.0

1.6

1.17

g/l

0.07

151

741

(3004789) Transferrin [Mass/volume] in Serum or Plasma

616

4337

1.51

17.65

2.9

2.5

2.33

2.30

g/l

0.43

560

4016

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

169

827

2.10

17.50

3.9

2.4

3.41

3.58

g/l

0.82

161

772

(3009261) Glucose [Presence] in Urine by Test strip

1670

14078

1.35

16.94

4.6

3.7

0.00

estimate

1.32

357

2543

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

379

2.60

16.87

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

905

6912

1.42

16.86

1.6

20.41

20.25

nmol/l

0.11

784

5909

(3009445) Proteinase 3 Ab [Units/volume] in Serum

220

1198

1.89

16.82

1.5

25.83

18.88

u/ml

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

501

3408

1.55

16.78

3.9

4.1

233.14

247.50

u/l

1.57

469

3215

(3018095) Leukocytes [#/volume] in Urine

1276

10337

1.37

16.63

4.7

3.7

117.65

111.29

e6/l

0.08

975

7380

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2066

18022

1.35

16.58

3.7

3.1

53.49

50.85

u/l

0.59

1918

16669

(3035350) Ketones [Presence] in Urine by Test strip

1653

13944

1.35

16.54

4.6

3.7

0.00

estimate

1.34

385

2804

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

138

3.74

16.54

1.2

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

4.72

16.33

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

496

3388

1.54

16.27

2.0

1.7

—

(3015736) pH of Urine

1365

11209

1.36

16.19

4.2

3.4

6.08

5.84

1.26

713

(3021601) Nitrite [Presence] in Urine by Test strip

1645

13903

1.34

16.09

5.9

5.0

0.00

estimate

0.50

367

2632

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1456

12090

1.35

15.99

3.2

2.8

149.87

133.60

ug/l

0.84

1332

11137

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

574

4064

1.49

15.86

3.0

2.6

21.45

22.84

1.33

467

3457

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

271

1616

1.73

15.35

3.2

4.29

4.43

pmol/l

1.16

246

1418

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

176

919

1.96

15.26

1.7

1.6

230.00

336.10

titre

—

(3029937) Albumin [Presence] in Urine by Test strip

963

7552

1.38

15.05

5.1

4.1

0.00

estimate

1.28

348

2520

(40761511) CBC panel - Blood by Automated count

3109

29250

1.53

14.67

20.3

14.1

—

(3023520) Reticulocytes [#/volume] in Blood

395

2622

1.57

14.65

2.5

2.6

66.87

69.12

e9/l

0.60

302

1996

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1127

9129

1.34

14.12

3.5

3.2

32.71

37.02

u/l

0.69

1056

8673

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

450

3100

1.52

14.09

4.4

3.5

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

121

3.67

13.98

1.5

1.4

58.00

64.83

—

(3044889) 12 lead EKG panel

2240

20036

1.32

13.74

4.6

3.9

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

892

6995

1.37

13.72

2.7

2.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

849

6610

1.37

13.65

4.5

3.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1197

9821

1.33

13.64

3.5

3.4

2.34

2.35

mmol/l

2.04

1046

8605

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

271

2.69

13.55

2.5

2.3

—

(3027945) Reticulocytes/100 erythrocytes in Blood

493

3496

1.48

13.37

2.6

2.5

1.79

1.78

0.08

437

3088

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

200

1139

1.80

13.28

1.7

1.8

36.79

38.65

u/l

0.67

177

990

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

126

3.52

13.19

1.6

2.2

1927.20

1231.90

u/ml

0.22

126

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

282

1770

1.64

13.17

2.4

10.82

22.50

au/ml

2.70

132

(3021589) Normoblasts [#/volume] in Blood

1481

12565

1.31

13.14

12.6

9.7

0.00

e9/l

0.08

1245

10248

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

260

1602

1.67

13.05

1.3

43.70

52.31

au/ml

—

(3009343) pH of Capillary blood

292

1857

1.62

12.94

4.4

3.9

7.42

7.41

0.33

233

(3002032) Base excess in Venous blood by calculation

406

2798

1.51

12.64

4.5

3.8

1.60

2.03

mmol/l

1.95

331

2332

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

293

1881

1.61

12.49

4.5

3.9

5.10

5.16

kpa

0.55

274

1781

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

363

2454

1.53

12.35

4.4

3.9

1.22

1.23

mmol/l

1.19

325

2127

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

163

3.10

12.23

2.1

2.6

0.24

0.21

e9/l

0.53

145

(3021447) Carbon dioxide [Partial pressure] in Venous blood

405

2809

1.50

12.21

4.5

3.7

5.86

5.85

kpa

0.02

391

2719

(3014111) Lactate [Moles/volume] in Serum or Plasma

380

2602

1.52

12.18

7.4

6.9

1.39

1.38

mmol/l

0.06

369

2537

(3011412) CD3 cells [#/volume] in Blood

253

2.64

12.02

1.9

2.4

1.21

1.16

e9/l

0.22

229

(3020630) Protein [Mass/volume] in Serum or Plasma

369

2519

1.52

12.00

2.3

2.5

65.79

66.27

g/l

0.56

331

2295

(3043409) Potassium [Moles/volume] in Arterial blood

161

886

1.86

11.96

4.6

4.0

3.85

3.89

mmol/l

0.56

161

877

(3004588) Protein electrophoresis panel - Serum or Plasma

317

2096

1.56

11.91

2.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

305

2003

1.57

11.81

3.4

2.2

12.31

12.38

nmol/l

0.05

274

1760

(3023183) Ammonium ion [Moles/volume] in Plasma

123

621

2.02

11.79

3.0

2.8

32.85

36.56

umol/l

0.83

115

552

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

279

1795

1.60

11.79

4.5

3.8

1.53

1.90

mmol/l

0.90

195

1304

(3020891) Body temperature

202

1196

1.73

11.75

4.9

4.4

—

(3000991) Gas panel - Venous blood

362

2473

1.52

11.72

9.3

8.2

—

(3012501) Base excess in Blood by calculation

132

690

1.95

11.48

5.1

4.6

2.39

2.70

mmol/l

0.82

474

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

379

2632

1.49

11.33

3.6

2.9

265.56

212.65

ng/l

1.26

343

2401

(40767503) Oxygen content in Capillary blood by calculation

126

655

1.96

11.14

2.9

2.6

16.93

15.92

1.67

338

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

646

4959

1.37

11.07

3.5

2.8

1.01

1.09

e6/l

0.36

392

2820

(3042936) Bacteria identified in Isolate by Culture

553

4147

1.40

10.91

2.1

2.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

172

996

1.76

10.83

1.3

1.2

0.31

0.99

u/ml

1.29

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

272

1783

1.57

10.61

1.7

—

(3010421) pH of Blood

146

813

1.83

10.48

4.9

4.3

7.42

0.03

133

735

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

223

1402

1.63

10.36

1.6

1.7

1.55

1.54

g/l

0.10

196

1210

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

132

715

1.88

10.35

1.6

1.9

11.28

11.69

mg/l

0.18

119

657

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

175

2.83

10.26

2.0

2.5

471.86

545.07

e6/l

0.44

147

(1616796) Gas panel - Central venous blood

128

690

1.89

10.19

4.2

3.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

184

1106

1.70

10.16

2.0

1.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

198

1215

1.67

10.12

2.0

1.9

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

397

2.17

10.06

5.4

6.7

11.09

11.94

mg/l

1.04

368

(3037522) Nuclear Ab [Titer] in Serum

479

3555

1.40

10.00

1.5

1.3

600.90

523.39

titre

0.44

755

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

321

2.30

9.98

1.2

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

795

6385

1.32

9.94

1.8

1.7

11024073.15

25453600.14

pmol/l

0.59

635

5296

(3014148) Varicella zoster virus Ab [Titer] in Serum

285

2.38

9.88

1.2

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

483

3597

1.40

9.88

9.8

7.3

—

(3000060) B lymphocytes [#/volume] in Blood

4.26

9.83

2.0

2.1

164.55

148.97

e6/l

0.13

(3028026) IgM [Mass/volume] in Serum or Plasma

250

1637

1.57

9.81

2.1

1.9

1.40

g/l

0.01

231

1484

(3006245) CD3-CD19+ cells/100 cells in Blood

3.54

9.76

2.0

2.2

12.88

9.37

0.78

(40758558) Short blood count panel - Blood

884

7221

1.30

9.73

7.4

6.6

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

143

811

1.80

9.69

2.1

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1254

10706

1.27

9.69

4.9

3.9

—

(40761536) Microorganisms panel - Urine sediment

344

2425

1.46

9.51

4.9

4.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

267

1793

1.53

9.36

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

200

1257

1.63

9.33

2.3

1.9

2.21

2.65

ug/l

0.19

163

1106

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2765

25957

1.30

9.21

6.5

5.8

40.03

40.10

mmol/mol

0.12

2562

23898

(3023323) Follitropin [Units/volume] in Serum or Plasma

169

1023

1.68

9.12

1.7

1.4

27.10

28.68

iu/l

0.22

133

874

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

109

579

1.91

9.11

3.8

3.5

56.72

57.91

0.46

109

579

(3013512) EKG study

1010

8463

1.27

8.97

4.4

4.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

4.89

8.83

1.9

2.2

19.53

17.41

umol/l

0.25

(3002179) Metamyelocytes/100 leukocytes in Blood

313

2201

1.46

8.77

3.8

3.9

0.85

0.73

0.25

123

731

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

191

2.59

8.73

1.8

2.2

—

(40761535) Cells panel - Urine sediment

340

2432

1.44

8.70

4.1

3.4

—

(3019150) Specific gravity of Urine by Refractometry

757

6137

1.30

8.69

5.1

4.1

1.02

kg/l

0.05

924

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

105

562

1.89

8.60

6.4

5.5

398.71

3660.68

iu/ml

0.56

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

8.22

8.56

1.1

1.0

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

438

2.01

8.51

3.4

3.0

69.00

1842.55

u/ml

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

266

1823

1.50

8.48

3.9

3.2

128.27

127.99

g/l

0.07

256

1773

(3030905) Polymorphonuclear cells [#/volume] in Blood

104

561

1.88

8.33

3.8

3.3

3.72

4.21

e9/l

2.10

104

561

(3024354) Oxygen [Partial pressure] in Venous blood

323

2311

1.44

8.26

3.9

3.1

4.48

4.55

kpa

0.32

313

2227

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3122

29932

1.38

8.21

13.3

10.4

25.96

25.75

u/l

0.18

3002

28802

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

4.76

8.11

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

178

1135

1.60

7.87

5.5

4.1

24.63

24.84

mmol/l

0.41

158

1054

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

122

704

1.76

7.87

1.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

157

971

1.65

7.85

2.8

3.3

26.61

67.53

mg/l

2.12

128

782

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

153

941

1.65

7.82

2.8

3.3

1.35

2.35

ratio

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

172

1095

1.60

7.66

2.4

2.3

9.49

10.27

g/l

1.76

152

978

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.27

7.65

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

156

970

1.64

7.64

2.8

3.3

35.00

119.92

mg/l

0.82

126

779

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

142

863

1.67

7.60

2.0

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

422

1.97

7.58

1.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

425

3235

1.36

7.53

2.8

7.54

9.14

umol/l

0.84

360

2832

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

3.39

7.51

1.6

1.2

30.63

20.08

—

(3002385) Erythrocyte distribution width [Ratio]

2586

24264

1.25

7.51

24.4

17.6

15.09

14.99

0.36

2547

23795

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

283

2.18

7.44

2.3

2.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

583

4657

1.30

7.38

3.7

3.0

2.51

2.23

e6/l

0.29

325

2538

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

490

1.88

7.37

2.3

1.9

176.23

202.08

pmol/l

1.17

460

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

667

5429

1.28

7.30

2.9

3.0

2.45

2.46

mmol/l

0.73

589

4741

(3005322) IgE [Units/volume] in Serum or Plasma

234

1617

1.48

7.19

1.2

1.3

315.65

189.62

u/ml

0.53

217

1482

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

334

2.06

7.17

1.6

1.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

510

1.85

7.13

1.5

—

(3000494) Fungus identified in Specimen by Culture

425

3272

1.34

6.98

1.6

1.4

—

(4035726) Immunohistochemistry procedure

344

2569

1.38

6.87

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

404

1.93

6.77

1.7

1.6

0.64

0.83

g/l

1.07

305

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

121

728

1.69

6.77

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

630

5139

1.28

6.73

1.6

1.5

2.29

2.49

g/l

1.60

376

3123

(3017181) Myelocytes/100 leukocytes in Blood

327

2438

1.38

6.60

3.9

4.0

0.98

0.92

0.13

127

864

(3010838) Calcium [Moles/time] in 24 hour Urine

472

1.84

6.60

1.9

4.75

4.99

mmol/24h

0.30

405

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

301

2216

1.39

6.56

4.4

4.0

108.47

91.01

ng/l

1.55

258

1901

(3025159) Blasts/100 leukocytes in Blood

295

2167

1.39

6.52

3.8

4.1

0.68

0.40

0.18

598

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

175

1170

1.52

6.34

2.3

2.2

3.61

3.69

g/l

0.31

157

1059

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

175

1171

1.52

6.31

2.4

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

175

1172

1.52

6.29

2.4

2.2

7.40

7.41

g/l

0.02

157

1060

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

104

614

1.71

6.26

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

104

614

1.71

6.26

1.4

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

210

1463

1.46

6.22

4.2

3.3

25.10

25.31

mmol/l

0.42

200

1416

(3022313) Gas panel - Capillary blood

194

1331

1.48

6.21

5.2

4.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.06

6.18

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.06

6.18

1.2

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.35

5.99

1.2

1.1

—

(40768797) Stomach Pathology biopsy report

485

3892

1.29

5.87

1.3

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

319

1.96

5.82

3.9

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

167

2.35

5.81

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

118

736

1.62

5.80

3.0

3.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

307

2316

1.36

5.77

3.9

4.1

0.09

0.12

0.31

107

742

(3009508) Creatinine [Moles/volume] in Urine

1040

9092

1.20

5.72

3.4

3.2

7.04

7.45

mmol/l

2.29

881

7648

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

859

7373

1.22

5.71

1.7

1.6

1.37

1.35

mmol/l

0.22

737

6155

(3048689) Calprotectin [Mass/mass] in Stool

403

3168

1.31

5.71

2.0

2.3

141.04

144.53

ug/g

0.06

317

2516

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2777

26494

1.23

5.68

19.4

14.0

79.06

78.82

ml/min/173m2

0.21

2389

21858

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

548

1.72

5.67

1.5

1.2

1.48

3.50

u/ml

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

203

1432

1.44

5.66

4.7

4.1

23.61

24.17

mmol/l

2.14

198

1396

(3011985) Renin [Units/volume] in Plasma

359

1.88

5.60

1.5

1.4

86.22

43.26

mu/l

0.51

316

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

12.89

5.58

1.1

1.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

111

689

1.63

5.57

2.3

1.8

45.39

42.08

nmol/l

0.53

106

663

(3019225) pH of Specimen

371

2896

1.31

5.53

5.3

4.4

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

5.38

5.53

1.1

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

10.02

5.52

1.2

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.00

5.52

1.2

1.1

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

340

1.90

5.50

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

340

1.90

5.50

1.5

—

(3014271) Vancomycin [Susceptibility]

153

2.37

5.47

2.7

3.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

109

677

1.63

5.47

1.4

1.2

14.44

8.15

u/ml

0.39

(3028679) Herpes simplex virus Ab [Presence] in Serum

129

2.49

5.44

1.1

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

121

772

1.59

5.44

5.4

3.8

1.67

1.58

mg/l

0.58

111

699

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

110

687

1.62

5.40

1.5

1.2

7.99

7.33

u/ml

0.06

110

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

161

1097

1.49

5.37

2.3

2.92

2.99

g/l

0.37

142

986

(3036180) Methadone [Presence] in Urine

2.87

5.34

1.3

2.0

—

(21491868) Cryoglobulin [Mass/volume] in Serum

101

2.69

5.33

1.1

1.3

—

0.24

g/l

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

528

1.70

5.32

1.6

1.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.55

5.32

1.5

—

(3004451) EKG impression Narrative

149

2.36

5.31

1.5

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

3211

31208

1.33

5.30

31.2

21.9

39.71

40.03

1.02

2951

29036

(3034426) Prothrombin time (PT)

2.79

5.30

1.4

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

357

2791

1.31

5.27

2.0

2.2

0.21

g/l

0.13

329

2601

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.84

5.24

1.1

87.23

87.67

0.03

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

517

1.70

5.18

1.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.80

5.13

1.2

1.3

85.50

83.29

0.09

(3007461) Platelets [#/volume] in Blood

3211

31227

1.32

5.12

30.9

21.8

246.32

248.04

e9/l

0.76

3141

30357

(3012516) Albumin [Mass/volume] in Urine

984

8635

1.19

5.09

3.6

3.3

673.06

332.03

mg/l

1.05

653

5571

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

467

1.73

5.09

1.2

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

125

817

1.55

5.08

1.8

1.7

—

(3024928) Oxygen saturation in Venous blood

612

1.64

5.08

3.6

3.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

198

2.13

5.03

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

198

2.13

5.03

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

198

2.13

5.03

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2843

27276

1.22

5.03

5.1

4.6

5.97

5.98

mmol/l

0.20

2591

24736

(3024731) MCV [Entitic volume]

3211

31241

1.31

4.99

30.8

21.8

91.46

91.22

2.19

3161

30735

(3023511) Choriogonadotropin [Units/volume] in Urine

359

1.83

4.98

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2757

26379

1.21

4.98

4.4

3.9

1.33

1.29

mmol/l

1.85

2531

23952

(3035941) MCH [Entitic mass]

3211

31243

1.31

4.97

30.8

21.7

30.39

30.35

0.72

3161

30735

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

114

734

1.57

4.96

1.5

1.2

62.80

42.15

u/ml

—

(3010813) Leukocytes [#/volume] in Blood

3211

31244

1.31

4.96

30.9

21.8

7.00

6.80

e9/l

2.50

3124

30266

(3026361) Erythrocytes [#/volume] in Blood

3211

31245

1.31

4.95

30.9

21.8

4.41

4.46

e12/l

6.85

3128

30277

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.34

4.93

1.1

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.67

4.92

1.3

2.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

200

2.11

4.91

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

200

2.11

4.91

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

200

2.11

4.91

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

3211

31254

1.31

4.87

31.2

22.0

133.05

134.51

g/l

6.56

3162

30754

(3020682) Albumin/Creatinine [Ratio] in Urine

1031

9120

1.18

4.82

4.2

3.8

12.20

9.23

mg/mmol

0.90

660

5810

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.23

4.81

1.1

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.84

4.80

1.1

1.2

—

(3028433) Virus identified in Specimen by Culture

2.68

4.74

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

315

1.86

4.71

1.4

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

123

819

1.52

4.63

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

146

2.27

4.63

1.2

1.3

135.91

134.91

nmol/l

0.05

146

(3006184) Hemoglobin [Mass/volume] in Capillary blood

107

691

1.57

4.62

2.3

2.2

132.75

127.47

g/l

1.23

502

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

140

2.30

4.61

1.2

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1799

16674

1.16

4.60

2.8

—

(3017704) Immunofixation for Urine

179

2.14

4.59

1.2

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

399

1.74

4.57

1.5

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

234

1.98

4.54

1.2

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

483

1.67

4.54

1.4

1.3

337.59

273.20

u/ml

0.93

290

(3052851) Hemolysis interference index of Serum or Plasma

127

856

1.50

4.52

3.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

123

827

1.50

4.44

1.2

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

129

877

1.49

4.42

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

245

1.93

4.34

1.7

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2859

27546

1.20

4.30

5.0

4.4

4.37

4.60

mmol/l

26.96

2643

25403

(3032352) Blasts [#/volume] in Cerebral spinal fluid

5.51

4.28

2.0

2.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

126

2.31

4.26

2.3

2.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

123

835

1.49

4.25

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

122

827

1.49

4.25

2.0

2.1

0.00

g/l

-0.00

112

756

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

333

2660

1.28

4.20

2.9

2.4

133.20

57.58

u/l

0.33

289

2264

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

133

920

1.46

4.19

2.0

36.91

37.60

g/l

0.70

114

809

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

456

1.66

4.17

1.5

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

249

1.90

4.15

1.5

1.3

0.39

0.41

g/l

0.19

170

(3027135) IgG subclass 1 [Mass/volume] in Serum

249

1.90

4.15

1.5

1.3

6.40

7.00

g/l

0.60

170

(3028192) IgG subclass 2 [Mass/volume] in Serum

249

1.90

4.15

1.5

1.3

2.92

2.86

g/l

0.08

169

(3000570) Elastase.pancreatic [Mass/mass] in Stool

120

818

1.48

4.08

1.3

1.4

284.80

275.95

ug/g

0.19

475

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.71

4.08

1.2

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

677

5850

1.19

4.06

1.3

1.99

1.52

u/ml

0.38

167

1520

(3021901) Oxygen saturation in Capillary blood

585

1.57

4.05

2.5

3.0

—

(40768804) Tissue Pathology biopsy report

1266

11509

1.16

4.04

2.2

2.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2913

28155

1.20

4.02

5.6

4.9

2.51

2.71

mmol/l

24.68

2682

25809

(4062490) Immunoglobulin typing, IgG

252

1.88

4.02

1.5

1.3

—

(40768446) Kidney Pathology biopsy report

111

2.35

3.99

1.7

1.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.68

3.98

1.2

1.0

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

533

1.59

3.96

1.4

1.2

63.29

43.51

u/ml

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

327

1.76

3.93

2.0

1.5

0.25

0.31

nmol/l

0.72

255

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

119

817

1.47

3.92

2.0

2.1

0.00

g/l

-0.00

111

755

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

141

1000

1.43

3.92

2.3

0.88

1.07

g/l

0.26

120

867

(3002079) Sodium [Moles/time] in 24 hour Urine

112

2.33

3.91

1.3

133.06

163.32

mmol/24h

1.48

112

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

112

2.33

3.91

1.1

0.12

8.68

nmol/l

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.07

3.89

1.4

2.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.79

3.89

1.4

1.5

—

(3016038) Potassium [Moles/volume] in Urine

185

2.01

3.88

1.8

1.2

35.23

35.68

mmol/l

0.04

159

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2832

27336

1.18

3.81

4.9

4.4

1.42

1.45

mmol/l

5.04

2609

25040

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

120

2.26

3.80

1.4

1.6

1.78

9.14

nmol/l

1.21

101

(3027456) Digoxin [Moles/volume] in Serum or Plasma

660

1.51

3.77

3.6

3.1

0.89

0.82

nmol/l

0.34

503

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.65

3.72

6.4

8.3

—

(3042733) HLA Ab [Presence] in Serum

2.57

3.71

5.5

4.9

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

161

2.06

3.70

2.1

2.8

43.28

40.29

0.38

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

287

2288

1.28

3.70

3.1

2.7

62.38

63.87

ml/min/173m2

0.26

128

933

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

168

2.03

3.69

1.3

—

(3049717) Cytology report of Urine Cyto stain

161

1182

1.38

3.68

2.4

2.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

403

1.65

3.66

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

109

747

1.47

3.65

1.3

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

3.12

3.64

1.0

1.4

4.04

738895.18

nmol/l

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

169

2.02

3.64

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

160

2144

0.73

3.59

1.8

1.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.66

3.56

1.0

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

345

1.69

3.55

1.6

58.84

61.54

0.19

217

(36660697) Celiac disease serology panel - Serum

264

2095

1.28

3.54

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

6.16

3.50

4.8

5.8

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

124

879

1.43

3.49

2.0

2.1

0.03

0.02

g/l

0.15

113

806

(3051651) Icteric interference index of Serum or Plasma

165

2.01

3.49

3.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.71

3.48

5.4

8.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

138

1000

1.40

3.44

2.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

208

1.88

3.44

1.9

1.5

1.17

1.16

promille

0.02

164

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

116

815

1.44

3.43

1.6

1.5

0.10

7.87

iu/ml

0.58

175

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

126

2.15

3.41

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

201

1547

1.32

3.40

2.3

2.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

327

1.69

3.39

1.4

2.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

107

2.25

3.38

1.8

2.2

—

(3037756) Immunofixation for Serum or Plasma

653

1.48

3.36

1.5

1.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.92

3.29

6.2

8.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.48

3.29

1.0

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1261

0.67

3.28

1.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

488

1.55

3.24

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

489

1.55

3.21

1.5

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

489

1.55

3.21

1.5

1.6

—

(21494755) Public health laboratory ask at order entry panel

166

2164

0.76

3.12

1.3

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

833

7466

1.15

3.11

4.1

3.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.67

3.08

1.0

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

3.67

3.08

3.5

2.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

592

1.48

3.07

1.6

1.7

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.44

3.04

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

119

2.11

3.04

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

119

2.11

3.04

1.2

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

2.90

3.02

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.84

3.02

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

677

1.45

3.02

1.2

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

842

7575

1.15

2.97

3.1

2.7

3131.32

5530.21

umol/l

1.23

704

6578

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.55

2.95

1.0

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

525

4561

1.18

2.94

1.3

44.59

35.39

iu/ml

0.34

149

1484

(3016228) CD19 cells/100 cells in Blood

114

2.11

2.94

1.7

2.1

8.25

8.79

0.12

107

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

623

1.46

2.93

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.25

2.93

1.2

1.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

649

1.44

2.91

1.4

1.5

—

(3025941) Bacteria identified in Stool by Culture

195

1532

1.29

2.88

1.2

—

(1761868) Lipid panel - Serum or Plasma

848

9364

0.88

2.87

3.2

2.9

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.51

2.87

1.8

1.5

0.66

0.35

ug/l

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.34

2.81

1.1

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

103

1417

0.72

2.80

1.5

1.4

—

(3017509) Phencyclidine [Presence] in Urine

4.45

2.79

1.7

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

292

1.65

2.78

1.5

1.7

—

(3023419) Bacteria identified in Sputum by Culture

458

1.52

2.77

3.0

2.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

450

1.52

2.77

1.2

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

339

1.60

2.76

4.8

6.1

6.70

7.33

mmol/l

0.93

284

(3037121) Protein [Mass/volume] in Urine

139

1049

1.34

2.75

3.1

3.0

0.36

0.28

g/l

0.48

424

(3052592) Norovirus Ag [Presence] in Stool

2.51

2.70

1.3

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

6.01

2.70

1.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.01

2.69

6.6

6.7

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.29

2.67

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

528

1.47

2.66

1.6

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

340

2869

1.20

2.66

1.7

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.26

2.60

2.3

2.9

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

107

2.06

2.57

1.0

1.1

1473.36

1622.43

miu/ml

0.22

107

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

354

1.56

2.56

1.4

—

(3011325) HIV 1+2 Ab [Presence] in Serum

5.46

2.54

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

331

1.58

2.54

1.3

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

4.38

2.47

1.6

1.3

43.57

43.56

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

350

1.55

2.45

1.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

2.14

2.44

1.1

1.2

0.30

g/l

0.09

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

174

1.79

2.41

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

321

1.57

2.38

1.2

1.3

—

nmol/l

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

345

1.54

2.37

1.5

1.4

—

(3036603) Volume of Urine

183

1.76

2.35

1.3

1.4

1936.38

1911.34

0.05

177

(3004616) Nuclear Ab [Presence] in Serum

330

1.55

2.35

1.5

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

346

1.54

2.35

1.5

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

176

1.77

2.33

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

323

1.56

2.32

1.6

2.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

347

1.54

2.32

1.5

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

688

1.38

2.31

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

112

1.97

2.30

1.1

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

348

1.53

2.29

1.4

—

(3008898) HLA-B27 [Presence]

111

836

1.34

2.28

1.1

—

(4200892) Spirometry reversibility

240

1990

1.22

2.28

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

700

1.37

2.25

1.4

1.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

171

1.76

2.24

1.4

2.2

14.08

25.58

umol/l

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

523

1.42

2.24

1.8

1.5

—

(3003694) ABO and Rh group [Type] in Blood

828

7569

1.12

2.23

1.4

—

(3019977) pH of Arterial blood

164

1.77

2.22

2.4

2.8

7.43

7.42

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

474

1.44

2.22

1.6

1.5

111.24

118.27

u/ml

0.17

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

5.56

2.21

1.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

402

3502

1.17

2.21

4.9

4.5

33.06

32.69

0.30

323

2340

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

534

1.41

2.18

1.6

1.4

—

20.31

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

218

1.66

2.18

1.3

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

510

1.42

2.16

4.0

3.2

—

(3000012) Reticulocyte production index

444

1.45

2.15

1.8

2.2

—

(3029075) Extractable nuclear Ab panel - Serum

2.17

2.14

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

167

1.74

2.11

1.7

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

167

1.74

2.11

1.7

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

371

0.54

2.11

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.20

2.09

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

382

0.55

2.08

1.5

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.71

2.07

2.0

2.5

—

11.38

—

(3005033) Fetal Nuchal fold Thickness US

368

0.54

2.06

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.03

2.05

3.1

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.03

2.05

3.1

2.6

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.50

2.05

1.0

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

110

1.91

2.05

2.6

1.7

184.50

114.31

umol/l

0.35

(3020876) Protein [Mass/time] in 24 hour Urine

318

1.52

2.03

2.0

2.4

0.74

1.55

g/24h

1.70

161

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

215

1.63

2.03

1.3

1.1

41.14

66.08

u/ml

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

102

775

1.33

2.01

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

487

4338

1.14

1.98

1.2

7.37

13.14

u/ml

1.36

153

1648

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

273

1.54

1.94

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

290

1.52

1.92

2.7

3.3

56.95

56.04

0.08

241

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

635

1.35

1.90

2.0

1.8

6.49

4.84

iu/l

0.38

208

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.96

1.89

1.6

2.1

—

(3042631) Mycobacterium sp identified in Specimen

415

1.43

1.88

4.4

2.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

481

0.62

1.87

1.4

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

444

0.61

1.87

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

443

0.61

1.85

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

442

0.61

1.84

1.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

253

1.55

1.84

1.3

1.40

1.43

nmol/l

0.06

228

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

441

0.61

1.83

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

727

1.32

1.81

1.5

1.6

—

(3044927) Protein electrophoresis panel - Urine

319

1.48

1.80

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.05

1.80

1.3

1.0

—

(3051611) Lipemic interference index of Serum or Plasma

295

1.50

1.79

3.3

3.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

287

1.50

1.79

2.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

208

1.59

1.76

1.1

1.3

8.31

9.30

mmol/l

0.79

202

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

193

1.61

1.74

1.7

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

112

883

1.28

1.73

2.2

1.8

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.92

1.72

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

161

1329

1.22

1.67

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.19

1.67

2.7

2.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

750

1.29

1.61

1.4

1.3

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.00

1.58

3.0

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

114

1.76

1.56

1.0

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.85

1.55

1.2

42.95

39.09

g/l

—

(3004809) Band form neutrophils/100 leukocytes in Blood

475

1.35

1.54

3.4

1.56

0.00

417

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

265

1.48

1.53

1.6

1.5

31.37

29.36

0.13

165

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

142

0.42

1.51

17.2

12.5

626.33

850.41

nmol/l

—

137

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.86

1.50

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

367

1.40

1.49

2.5

2.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

187

2195

0.84

1.49

1.3

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

202

1.54

1.48

1.2

1.1

—

(3021788) Differential panel - Synovial fluid

514

1.33

1.47

1.5

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

202

1729

1.18

1.46

1.2

141.88

151.24

iu/ml

0.12

624

(46235355) HIV 1 and 2 tests - Meaningful Use set

466

4231

1.12

1.43

1.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.79

1.43

1.1

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

362

1.39

1.42

1.5

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

320

1.41

1.42

1.8

1.4

22.36

26.90

u/l

0.44

262

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

817

0.75

1.41

1.4

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

224

1942

1.16

1.39

1.5

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

337

3007

1.13

1.39

1.6

1.8

1.59

1.50

1.06

291

2636

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.00

1.38

1.1

0.56

0.71

umol/24h

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

460

1.33

1.36

1.5

1.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.83

1.35

1.1

1.5

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

143

1.61

1.35

1.1

1.2

200.13

389.12

u/l

0.93

129

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.87

1.34

1.3

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

282

1.42

1.33

1.1

—

(3011648) Oxygen content in Venous blood

224

1.48

1.33

3.9

2.6

10.56

11.16

0.35

224

(1001926) Buprenorphine [Presence] in Urine by Screen method

568

1.29

1.31

1.4

1.9

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

212

1840

1.16

1.31

1.5

1.4

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

1.74

1.31

1.7

2.06

1.98

umol/l

0.16

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

542

5879

0.91

1.30

3.0

3.1

0.78

0.80

ug/l

0.09

378

4033

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

259

1.43

1.29

1.1

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.78

1.28

1.6

1.4

379.40

391.94

umol/24h

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.78

1.28

1.6

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

210

1.48

1.27

1.4

1.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

134

0.45

1.27

1.2

1.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.79

1.27

1.1

—

(4146454) Self-monitoring of blood glucose

311

1.39

1.26

2.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

392

3554

1.12

1.26

1.6

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

2.40

1.24

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.22

1.24

1.1

1.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

2.22

1.24

1.1

79.41

71.25

ug/l

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.97

1.22

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.31

1.18

2.2

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.11

1.18

1.1

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

1.16

0.0

10.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

325

1.36

1.15

1.0

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

110

1.64

1.15

3.3

2.6

—

(3024932) HLA-DR beta [Type]

1.75

1.12

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

540

0.74

1.12

1.5

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

103

1.65

1.12

1.2

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.90

1.12

1.1

1.2

—

(3017569) Oxygen content in Arterial blood

143

1.54

1.11

1.5

2.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.26

1.10

3.9

2.7

0.43

0.58

u/field

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.38

1.09

2.0

2.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.73

1.08

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.95

1.08

1.4

1.6

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.95

1.08

1.1

1.4

25.63

24.75

pmol/l

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

721

1.23

1.07

2.1

2.2

129.99

103.04

ug/min

0.35

438

(21494434) Karyotype in Bone marrow

278

1.37

1.07

1.2

—

(3000492) Spirometry study

294

2652

1.12

1.06

1.5

—

(3003338) MCHC [Mass/volume]

2413

23625

1.07

1.06

27.3

19.2

331.94

332.10

g/l

0.35

2384

23420

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

178

1.46

1.05

1.6

1.5

9.05

7.13

u/l

0.21

147

(3024471) HLA-A [Type]

1.71

1.05

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

366

1.32

1.05

2.2

2.1

24.24

22.17

mg/l

0.09

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

715

1.22

1.04

2.6

2.0

4798.46

4278.32

u/l

0.06

275

(3032868) Hemoglobin electrophoresis panel in Blood

2.27

1.03

2.0

1.5

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

2.27

1.03

4.8

4.1

2.23

2.07

mg/l

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.06

1.02

1.0

1.2

—

719.96

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

431

1.28

0.99

1.1

121.80

1360.33

iu/ml

0.48

(3015183) Erythrocyte sedimentation rate

133

0.53

0.98

1.0

1.2

—

(3045424) Erythrocytes [Presence] in Urine

459

1.27

0.98

1.3

1.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.85

0.96

1.2

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.95

0.0

1.8

—

(3003129) Base excess in Capillary blood by calculation

1.69

0.95

2.0

1.8

0.78

0.91

mmol/l

0.04

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

259

1.35

0.95

1.1

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

151

1.46

0.90

1.6

1.4

1.16

1.14

nmol/l

0.04

116

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.75

0.90

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

101

0.49

0.89

1.8

2.5

637.60

762.27

e6/l

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.07

0.89

1.0

1.1

—

(3047189) Immunofixation for 24 hour Urine

152

1.45

0.88

1.3

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

103

1.56

0.87

1.1

1.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

220

1.37

0.87

1.3

1.2

121.25

137.27

titre

—

(3000475) Leukocytes [#/volume] in Synovial fluid

704

1.20

0.86

1.6

1.7

5712.82

14621.22

e6/l

2.88

500

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

391

0.74

0.86

1.4

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

170

1.41

0.85

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1065

10230

1.06

0.85

4.8

5.2

3.71

3.56

ug/l

0.05

948

9135

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

1.63

0.84

1.8

1.3

29.83

28.40

—

(3044242) Glucose [Moles/volume] in Arterial blood

154

1.43

0.83

1.5

2.3

—

(3016879) Cocaine [Presence] in Urine

680

1.20

0.83

1.6

2.1

—

(3035880) pH of Pleural fluid

180

1.39

0.81

1.2

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

421

0.76

0.81

1.5

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.58

0.81

2.1

1.3

83.64

141.15

nmol/24h

0.36

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

147

1.43

0.80

9.2

3.9

—

(3006270) Folate [Moles/volume] in Blood

259

1.32

0.79

1.1

1.2

306.48

353.21

nmol/l

0.72

224

(3006462) Nitrate [Presence] in Urine

139

1.44

0.79

2.8

3.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

429

1.24

0.78

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.51

0.78

1.6

2.3

161.40

143.53

nmol/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.59

0.78

1.3

2.0

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

252

1.31

0.76

3.2

4.2

20.06

47.39

u/ml

2.34

252

(3027944) Amphetamines [Presence] in Urine

725

1.18

0.75

1.6

2.0

—

(3044941) Cell count panel - Synovial fluid

459

1.22

0.74

1.5

1.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.08

0.74

1.0

1.3

3.60

15.63

u/l

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

201

1.35

0.74

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.84

0.73

2.3

2.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.84

0.73

2.3

2.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

133

1.43

0.73

1.1

1.0

0.15

0.86

u/ml

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

718

1.17

0.72

1.1

9.25

5.17

u/ml

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.62

0.71

1.4

2.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

364

3898

0.93

0.71

1.5

1.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.75

0.71

10.7

13.7

5.17

5.56

mmol/l

—

(3019174) dRVVT (LA screen)

1.92

0.70

1.2

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.92

0.70

2.2

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

238

1.31

0.70

2.3

1.7

3.07

4.45

mg/l

2.55

231

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

738

0.84

0.69

1.4

1.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

482

1.21

0.69

1.8

1.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.53

0.68

1.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

204

0.69

0.68

3.3

2.3

—

(3022145) Colonoscopy Study observation

337

3141

1.08

0.68

1.4

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

295

0.74

0.67

1.5

—

(3027008) Opiates [Presence] in Urine

734

1.16

0.66

1.6

2.0

—

(3045414) Leukocytes [Presence] in Urine

144

1290

1.12

0.66

1.9

—

(3039443) Prostate specific Ag panel - Serum or Plasma

505

0.81

0.65

1.5

1.7

—

(3002256) Pathology report gross observation

358

3820

0.93

0.65

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

1.73

0.64

1.0

1.4

—

(4212803) Bone marrow aspirate examination

1.73

0.64

1.0

1.1

—

(3028300) Cannabinoids [Presence] in Urine

738

1.16

0.63

1.6

2.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

443

1.20

0.61

1.3

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

1.67

0.61

1.6

1.3

—

(3017732) Neutrophils [#/volume] in Blood

211

1939

1.09

0.61

2.6

3.2

5.62

5.35

e9/l

0.10

163

1551

(3000764) Benzodiazepines [Presence] in Urine

731

1.15

0.61

1.6

2.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

467

0.81

0.60

5.3

3.8

23.95

34.56

u/ml

1.05

454

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.72

0.57

1.2

1.60

1.79

umol/24h

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.67

0.56

1.0

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

146

0.68

0.52

1.2

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.50

0.51

1.2

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

189

1.27

0.49

2.0

1.5

83.96

82.77

umol/l

0.07

189

(3000093) Morphology [Interpretation] in Blood Narrative

271

1.22

0.48

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

189

0.74

0.48

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

221

0.77

0.46

1.1

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

228

1.23

0.45

1.3

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

652

0.87

0.44

4.2

3.5

19.28

27.39

mg/l

1.11

409

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

141

0.71

0.44

1.3

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

449

4299

1.05

0.44

1.6

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

152

0.72

0.44

1.5

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

152

0.72

0.44

1.5

1.8

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

163

0.74

0.43

6.3

3.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

175

1.26

0.43

1.4

190.17

212.04

pmol/l

0.15

175

(3045142) Bone marrow Pathology biopsy report

332

1.18

0.41

1.2

1.3

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

26.80

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.41

0.0

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.41

0.0

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

738

1.11

0.41

1.2

93.33

94.17

titre

0.01

(3025130) Human papilloma virus identified in Specimen

304

0.82

0.40

1.5

1.8

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

123

1.30

0.40

1.2

1.0

12.92

0.43

u/ml

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.47

0.40

1.2

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

814

0.89

0.40

1.3

1.4

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

1.1

—

36.28

—

(40768800) Prostate Pathology biopsy report

655

0.88

0.39

1.0

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.34

0.39

2.8

2.4

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.36

0.38

1.1

1.2

18.09

17.28

umol/l

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

107

982

1.09

0.37

1.5

1.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

243

1.20

0.37

1.6

2.2

2.13

1.68

u/field

0.19

(40768793) Breast Pathology biopsy report

631

0.89

0.37

1.4

1.3

—

(40757373) Influenza virus identified in Isolate

1.27

0.36

1.1

1.6

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.43

0.35

1.8

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.63

0.35

1.2

1.4

14.81

8.71

ug/l

—

(3020491) Glucose [Moles/volume] in Blood

219

1.19

0.33

1.6

2.0

7.64

6.60

mmol/l

0.58

146

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

229

1.18

0.32

1.3

10.24

13.93

u/l

1.07

210

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

142

0.77

0.30

1.1

1.3

5.70

5.99

mmol/l

0.48

137

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

495

1.11

0.30

1.1

1.2

38.70

41.90

u/l

0.05

428

(1761482) Bacteria [#/volume] in Urine by Culture

787

0.91

0.30

5.6

4.3

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

111

1.26

0.30

1.1

1.8

24.22

90.27

ug/l

0.45

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

250

0.84

0.30

5.3

4.9

82.03

82.44

u/ml

—

(3024263) Appearance of Synovial fluid

158

1.20

0.28

1.4

1.5

—

(3022621) pH of Urine by Test strip

203

1935

1.05

0.28

3.5

3.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

308

1.14

0.27

3.3

3.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

396

0.88

0.27

1.0

1.1

1.78

4.63

u/ml

1.37

196

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.25

0.27

1.0

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

116

0.78

0.27

1.7

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

116

0.78

0.27

1.7

2.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

118

0.76

0.27

1.7

2.0

—

(3016750) Collection duration of Urine

178

1.18

0.26

2.0

2.1

483.50

494.45

min

0.20

132

(3047007) Chlamydophila sp Ab [Presence] in Serum

362

0.88

0.25

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

159

0.82

0.24

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

350

0.88

0.24

1.2

1.0

2.21

2.98

u/ml

0.24

155

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.17

0.24

1.1

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

783

1.07

0.24

2.8

2.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

380

0.89

0.23

1.0

1.1

0.22

1.69

u/ml

2.38

163

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.32

0.23

1.0

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

237

1.14

0.23

1.8

2.1

7.44

6.29

umol/l

0.23

162

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.28

0.23

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.28

0.23

1.0

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.28

0.23

1.0

1.3

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.28

0.23

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.28

0.23

1.0

1.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.24

0.23

1.2

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.75

0.22

1.3

1.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

189

0.85

0.22

1.4

1.5

0.92

0.95

g/l

0.13

189

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

267

1.12

0.21

1.4

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

267

1.12

0.21

1.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

267

1.12

0.21

1.4

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

401

1.10

0.21

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.19

0.21

1.4

1.1

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

1.58

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.21

0.0

3.4

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.03

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

182

1.15

0.21

1.1

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

156

0.83

0.21

1.3

1.70

1.57

g/l

0.92

156

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

8.06

—

(3000330) Specific gravity of Urine by Test strip

148

1546

0.96

0.20

4.3

3.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

438

0.91

0.20

1.1

1.26

2.33

u/ml

0.58

219

(40768443) Skin Pathology biopsy report

128

1223

1.05

0.19

1.2

—

(3004775) Volume in Urine collected for unspecified duration

243

1.11

0.17

1.9

2.2

705.41

631.61

0.40

161

(3003434) Protein [Mass/volume] in Pleural fluid

436

1.08

0.17

1.4

1.5

30.95

31.89

g/l

0.18

394

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.11

0.17

1.1

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.75

0.17

1.2

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.73

0.17

1.0

—

(4281824) Cell count and differential, peritoneal fluid

287

0.91

0.16

1.2

1.1

—

(3011288) Drugs identified in Urine by Screen method

506

1.07

0.15

1.9

2.7

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

193

0.88

0.15

1.1

1.0

766.25

305.39

ng/l

0.58

127

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

193

0.88

0.15

1.1

1.0

55.50

44.37

ng/l

0.57

124

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

193

0.88

0.15

1.1

1.0

741.55

693.35

ng/l

0.12

123

(3026692) Albumin [Mass/volume] in Peritoneal fluid

0.77

0.15

1.0

1.5

10.88

12.63

g/l

—

(3023199) Leukocytes [#/volume] in Pleural fluid

390

1.08

0.15

1.4

1363.97

1869.53

e6/l

0.57

276

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.14

0.15

3.1

1.7

—

(40768795) Lymph node Pathology biopsy report

274

1.10

0.15

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

159

1.13

0.15

1.1

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

1.08

0.14

1.8

1.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

304

1.09

0.14

1.0

9.26

2.57

u/ml

0.55

141

(3010144) Erythrocytes [#/volume] in Synovial fluid

285

1.09

0.14

1.6

1.4

296380.18

73731.88

e6/l

0.52

198

(3005570) Glucose [Moles/volume] in Urine

305

0.92

0.13

2.3

2.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

108

0.83

0.13

1.2

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

958

0.96

0.13

1.7

1.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

171

1.11

0.12

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

171

1.11

0.12

1.1

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

436

0.94

0.12

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

168

0.89

0.11

6.1

6.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

129

1252

1.03

0.11

1.6

1.8

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

949

1.03

0.10

1.6

1.7

3.09

4.24

mg/l

0.76

700

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

361

0.94

0.09

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

135

1.11

0.09

1.2

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.09

0.09

1.0

1.5

206.62

116.03

ng/l

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

813

8197

0.99

0.09

4.5

21.90

21.94

0.03

401

4150

(3045788) Cell count panel - Pleural fluid

311

1.06

0.09

1.3

1.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.11

0.09

3.0

2.9

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.09

0.08

2.8

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.05

0.08

1.0

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

123

0.89

0.08

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

687

1.03

0.08

1.2

1.3

186.32

219.64

miu/ml

0.42

314

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

295

2910

1.02

0.08

1.6

—

(4034850) Laboratory test

935

1.03

0.07

15.2

10.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

589

1.04

0.07

4.7

1.8

0.99

0.82

nmol/l

0.94

486

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

200

2033

0.98

0.07

1.8

1.9

—

(3033799) Differential panel - Peritoneal fluid

1.06

0.07

1.4

2.1

—

(40765096) Chromosome analysis panel by Banding

0.86

0.06

1.0

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

313

3165

0.99

0.06

3.5

4.0

45.53

23.99

ug/l

0.31

257

2601

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

111

0.90

0.06

1.6

1.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

345

1.04

0.06

1.5

1.4

78138.85

83864.93

e6/l

0.03

197

(3003740) Influenza virus B Ag [Presence] in Specimen

365

1.04

0.06

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

188

1.06

0.05

1.8

1.9

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

149

1.07

0.05

2.3

2.1

23.71

135.82

ug/min

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

357

1.04

0.04

1.0

1.1

1.16

1.69

u/ml

0.34

182

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

716

0.98

0.04

1.3

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

231

0.95

0.04

1.0

1.1

—

(40768806) Pleura Pathology biopsy report

338

1.04

0.04

1.3

1.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

101

1.09

0.04

1.1

1.2

—

(44813793) Dust mix specific IgE antibody measurement

170

1.06

0.04

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

210

1.05

0.03

1.3

1.2

—

titre

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

129

0.93

0.03

1.4

1.6

61.44

65.88

—

104

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

250

1.04

0.03

1.0

0.28

0.23

u/ml

—

(40768441) Liver Pathology biopsy report

201

1.05

0.03

1.6

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

180

1785

1.01

0.02

1.3

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

272

1.03

0.02

1.0

1.1

8.74

4.02

u/ml

—

104

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

110

1092

1.01

0.01

2.6

3.3

1036.56

4180.62

u/ml

0.61

936

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

156

0.96

0.00

1.1

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

156

0.96

0.00

1.1

1.6

—

(3012441) Differential panel - Pleural fluid

334

1.02

0.00

1.3

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

278

1.01

0.00

1.3

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

365

1.01

0.00

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

191

0.99

0.00

1.3

1.2

1.00

1.06

u/ml

—

107

(3000034) Microalbumin [Mass/volume] in Urine

279

1.00

0.00

2.9

3.1

30.33

38.28

mg/l

0.19

214

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

114

0.96

0.00

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

376

1.01

0.00

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

106

1.04

0.00

2.8

1.9

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

146

1.03

0.00

1.0

1.2

—

(1002224) Polysomnography panel

979

1.00

0.00

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

135

1349

1.00

0.00

1.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

483

0.99

0.00

1.1

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

743

1.00

0.00

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.85

-0.00

1.2

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

2.56

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

0.94

-0.00

1.2

1.6

—

6.72

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

6.8

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3020650) Glucose [Presence] in Urine

0.96

-0.00

1.3

1.5

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

0.21

—

(3022689) Creatine [Moles/volume] in Urine

0.92

-0.00

1.9

1.5

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

38.60

—

(3051101) Glucose [Moles/volume] in Cord blood

0.91

-0.00

6.8

6.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

249.11

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

0.85

-0.00

1.2

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.01

-0.00

1.1

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.2

—

3776.00

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

-0.00

0.0

7.3

—

79.00

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.85

-0.00

1.2

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

0.87

-0.00

2.2

2.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

-0.00

0.0

5.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

227

2270

1.00

-0.00

1.8

2.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3008607) Semen analysis panel

0.00

-0.00

0.0

1.3

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.85

-0.00

1.2

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_VISFIELDDEF and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_VISFIELDDEF	1.669 [1.52, 1.83]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.15

During the follow-up period (1.1.1998 — 31.12.2019), 2621 out of 10302 females with H7_VISFIELDDEF died.

Males

Parameter	HR [95% CI]	p-value
H7_VISFIELDDEF	1.77 [1.62, 1.94]	< 0.001
Birth year	0.983 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 3731 out of 10733 males with H7_VISFIELDDEF died.

Mortality risk

Mortality risk for people of age

years, who have H7_VISFIELDDEF.

N-year risk	Females	Males
1	0.172%	0.307%
5	0.864%	1.93%
10	2.355%	4.547%
15	4.659%	8.466%
20	7.991%	14.145%

Relationships between endpoints

↥

Index endpoint: H7_VISFIELDDEF – Visual field defects

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Visual field defects

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints